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Abstract
On circulating platelets, the integrin fibrinogen receptor &alphaIIb&beta3 favors inactive conformations.
Platelets rapidly activate &alphaIIb&beta3 to bind fibrinogen, mediating a platelet clot. Resting
&alphaIIb&beta3 is stabilized by interactions between the &alphaIIb and &beta3 transmembrane domains.
Binding of talin-1 and kindlin-3 to the integrin cytoplasmic domain stabilizes separation of the TMs and
receptor activation. Src family kinases are needed for transmission of extracellular signals into the cell. We
have sought to better understand how signals are transmitted across the &alphaIIb&beta3 TM domain. First
we characterized the structure and dynamics of the active and inactive integrin cytoplasmic domain to
determine how motifs that bind talin-1 and kindlin-3 are affected by the integrin activation state and the
membrane environment. The &alphaIIb&beta3 cytoplasmic domain is disorded, while the &beta3 subunit
contains two &alpha-helices, which interact with the phospholipid bilayer. The close proximity of &alphaIIb
to &beta3 in the inactive state induces a kink that projects the &beta-chain parallel to the membrane surface.
This kink is likely to stabilize interactions between helices in &beta3 with the membrane and possibly
compete with binding to talin-1 and kindlin-3. The &beta3 cytoplasmic domain becomes increasingly
dynamic further from the membrane, suggesting that distal kindlin-3 binding residues should be more
accessible to interact with their binding partners. We also studied the interaction between talin-1 and the
&beta3 cytoplasmic domain to determine how the membrane environment affects formation of the
talin-1/&beta3 complex. The membrane significantly increases the affinity of talin-1 for &beta3, but that the
ternary integrin/talin-1/membrane complex is not significantly more stable than the talin-1/membrane
complex alone. We also performed preliminary experiments characterizing the interaction between
&alphaIIb&beta3 and both kindlin-3 and c-Src. Unlike talin-1, kindlin-3 does not require the membrane to
bind the integrin cytoplasmic domain with high affinity. The interaction between c-Src and the integrin was
extremely weak suggesting that it might require colocalization through other interactions. Finally, we
developed a simplified model showing how thermodynamic coupling between integrin subunits might allow
&alphaIIb&beta3 to adopt multiple activation states.
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ABSTRACT 
 
THE INTEGRIN EQUILIBRIUM:  BALANCING PROTEIN-PROTEIN AND 
PROTEIN-LIPID INTERACTIONS 
 
David T. Moore 
 
William F. DeGrado 
 
On circulating platelets, the integrin fibrinogen receptor αIIbβ3 favors 
inactive conformations.  Platelets rapidly activate αIIbβ3 to bind fibrinogen, 
mediating a platelet clot.  Resting αIIbβ3 is stabilized by interactions 
between the αIIb and β3 transmembrane domains.  Binding of talin-1 and 
kindlin-3 to the integrin cytoplasmic domain stabilizes separation of the 
TMs and receptor activation. Src family kinases are needed for 
transmission of extracellular signals into the cell.  We have sought to 
better understand how signals are transmitted across the αIIbβ3 TM 
domain.  First we characterized the structure and dynamics of the active 
and inactive integrin cytoplasmic domain to determine how motifs that 
bind talin-1 and kindlin-3 are affected by the integrin activation state and 
the membrane environment. The αIIb cytoplasmic domain is disorded, 
while the β3 subunit contains two α-helices, which interact with the 
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phospholipid bilayer.  The close proximity of αIIb to β3 in the inactive state 
induces a kink that projects the β-chain parallel to the membrane surface.  
This kink is likely to stabilize interactions between helices in β3 with the 
membrane and possibly compete with binding to talin-1 and kindlin-3.  The 
β3 cytoplasmic domain becomes increasingly dynamic further from the 
membrane, suggesting that distal kindlin-3 binding residues should be 
more accessible to interact with their binding partners.  We also studied 
the interaction between talin-1 and the β3 cytoplasmic domain to 
determine how the membrane environment affects formation of the talin-
1/β3 complex.  The membrane siginificantly increases the affinity of talin-1 
for β3, but that the ternary integrin/talin-1/membrane complex is not 
significantly more stable than the talin-1/membrane complex alone.  We 
also performed preliminary experiments characterizing the interaction 
between αIIbβ3 and both kindlin-3 and c-Src.  Unlike talin-1, kindlin-3 does 
not require the membrane to bind the integrin cytoplasmic domain with 
high affinity.  The interaction between c-Src and the integrin was 
extremely weak suggesting that it might require colocalization through 
other interactions.  Finally, we developed a simplified model showing how 
thermodynamic coupling between integrin subunits might allow αIIbβ3 to 
adopt multiple activation states. 
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Chapter 1 Background 
I. Introduction  
 In multicellular organisms, integral membrane proteins mediate 
adhesion and signal transduction across the plasma membrane.  Such 
processes are often dynamically regulated and reversible, suggesting that 
they can be described as linked equilibria.  Changes in conformation, 
oligomeric state, or protein-protein contacts in extracellular, 
transmembrane (TM), and cytoplasmic domains can shift the equilibrium 
between different receptor functional states and transmit information 
across the membrane.  In order to develop effective therapies to target 
signaling receptors, these equilibria must be understood to prevent 
undesired side effects. The importance of understanding these processes 
is illustrated by the platelet fibrinogen receptor integrin, αIIbβ3.  Small 
molecules that mimic fibrinogen successfully block ligand binding to 
αIIbβ3, but stabilize active receptor conformations, resulting in either a 
paradoxical prothrombotic state or clearance of platelets and severe 
bleeding.  In the following chapters, the regulation of αIIbβ3 is discussed.  
In particular, we focus on the mechanisms of transmembrane signal 
transduction and how coupled protein-protein and protein-lipid interactions 
allow multidomain receptors such as αIIbβ3 to integrate multiple signals to 
produce surprisingly diverse functions.  
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II. Platelet integrins.   
Platelets are highly specialized cell fragments that are released 
from bone marrow megakaryocytes and are necessary for normal arterial 
clotting (4). Functional thrombocytopenia in the presence of normal 
platelet counts results from loss of the platelet fibrinogen receptor integrin 
αIIbβ3.   The integrin αIIbβ3 mediates formation of the platelet clot and 
patients whose platelets lack normal αIIbβ3 function present with the 
bleeding diathesis Glanzmann thrombasthenia (5, 6).  Severe bleeding 
can also result in patients with normal platelet counts and functional 
integrins via loss of signal transduction molecules that regulate the αIIbβ3 
(7-10).  Finally, a decreased number of circulating platelets 
(thrombocytopenia) can result from spurious activation of the receptor by 
small molecules or autoimmune antibodies (11).   
Resting platelets circulate with αIIbβ3 in an inactive conformation.  
In the presence of damaged vasculature, numerous signals are integrated 
by the platelet, culminating in the activation of αIIbβ3, which binds 
fibrinogen and von Willebrand’s factor to form a platelet plug (12).  The 
integrin family of receptors is ubiquitously expressed in metazoa (13).  
Functional receptors are heterodimeric, composed of α and β subunits 
(Figure 1.1).  Each subunit has a large ectodomain, a single 
transmembrane domain, and a relatively short cytoplasmic domain.  In 
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humans, there are eighteen α-chains and eight β-chains that combine to 
form 24 integrin heterodimers.  Although these receptors are differentially 
expressed, recognize unique ligands, and occupy distinct functional 
niches, they contain common structural elements.  In particular the 
transmembrane and cytoplasmic domains are highly conserved, 
consistent with their importance in regulating integrin function through 
protein-protein interactions (14).  
 
Figure 1.1  Simplified integrin equilibrium. 
Integrins are in equilibrium between inactive (left) and active (right) states.  
This equilibrium is modulated by both intracellular and extracellular 
events.  Integrins possess highly modular domain structures that 
communicate between each other establishing an elaborate coupled 
equilibrium.  Interactions between the intregrin TM domains stabilize the 
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inactive conformation.  Soluble factors can bind to each modular 
subdomain and shift the equilibrium between states. 
 
 On a resting platelet, the transmembrane and membrane-proximal 
domains of inactive αIIbβ3 form an extended heterodimeric interface (15-
17). Activation of αIIbβ3 requires TM domain separation.  This separation 
is dramatic (100 Å) and propagates to the ectodomain, stabilizing 
significant conformational changes that allow ligand binding (18).  The 
term “inside-out signaling” refers to the classical mode of integrin 
activation in which intracellular signaling molecules bind to the integrin 
cytoplasmic domain and stabilize separation of the α and β TM domains, 
which results in subsequent activation of the extracellular ligand binding 
site.  However, αIIbβ3 can also be activated through extracellular 
interactions.  This suggests that the activation state of αIIbβ3 can be 
described as a linked equilibrium in which intracellular, TM, and 
cytoplasmic conformational states are coupled and either stabilized or 
destabilized by interactions with other molecules.   
 Inside-out activation requires the evolutionarily related talin and 
kindlin protein families (19, 20).  There are two talin paralogs (talin-1 and 
2) and three kindlin paralogs (kindlin-1, 2, and 3).  In platelets, αIIbβ3 
requires talin-1 and kindlin-3 only (21) (22).  Patients who lack kindlin-3 
function have Leukocyte Adhesion Deficiency III (LAD-III) in which 
platelets are unable to activate αIIbβ3 and immune cells are unable to 
activate β2 integrins resulting in both severe bleeding and impaired 
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immune function (7-10).  Both talins and kindlins contain phospholipid 
binding domains, suggesting that their interactions with the inner leaflet 
may play a role in the regulation of αIIbβ3.   
 Integrin “outside-in signaling” can refer to one of two processes.  
The first is stabilization of an active integrin conformation by extracellular 
ligands.  The second refers to signaling events downstream of integrin 
activation and ligand binding.  Generally, these events require integrin 
oligomerization and involve recruitment of a number of signaling 
molecules including Src-family kinases (SFKs) (23).  However, the 
dynamics of the signaling complexes remains an area of active research.   
Talin and kindlin are members of the membrane-binding FERM 
(band 4.1/Ezrin/Radixin/Moesin) domain family.  Their interactions with the 
αIIbβ3 cytoplasmic domains are likely to occur simultaneously with binding 
to the plasma membrane. Therefore, any equilibrium description of 
integrin protein-protein interactions must include interactions with the inner 
membrane leaflet.  For simplicity, interactions between soluble proteins 
and the inner leaflet can be divided into two categories.  First, proteins can 
bind using a combination of nonspecific electrostatic interactions with lipid 
head groups and hydrophobic interactions through insertion of 
hydrophobic side chains (24, 25).  Second, there are a host of domains 
that differentiate between lipid head groups with a spectrum of specificity 
(26).  However, “non-specific” electrostatics are likely to play a role in even 
“specific” head group recognition as lipid binding domains are often 
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positively charged and the inner leaflet of the plasma membrane is greater 
than 20% negatively-charged phosphatidylserine (PS).    
  The majority of negatively-charged lipids reside on the inner leaflet 
of the plasma membrane bilayer.  PS is the most prevalent monovalent 
anionic lipid in mammalian cells and platelets, representing greater than 
20% of the inner leaflet (26).  The distribution of PS is asymmetric and it is 
actively transported from outer leaflet to the cytosolic face of the plasma 
membrane.  During apoptosis or platelet activation, PS redistributes such 
that roughly half is on both the outer and inner leaflets.  Exposed PS 
serves as an inflammatory nidus and a site for the assembly of clotting 
factor complexes. 
 The laboratories of Honig, McLaughlin, and Murray have developed 
models for negatively charged bilayers containing monovalent lipids (27, 
28). They found that the molar partition coefficient varies exponentially 
with the percentage of PS (28, 29), i.e. the ∆G of association is linear with 
percentage charged lipid concentration. These experiments were 
extended to the interaction of the myristoylated anchor of c-Src a kinase 
involved in outside-integrin signaling.  While the myristoyl tail produced 
significant thermodynamic driving force for membrane association, 
electrostatics increased the affinity significantly (29).  Phosphoinositides 
are negatively-charged lipids that exist in much lower concentrations than 
phosphatidylserine, but are more dynamically regulated to produce local 
concentrations of specific lipids to regulate signal transduction (26).  As 
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they contain a number of phosphates, they are negatively-charged and 
contribute a significant amount of electrostatic driving force to protein-lipid 
interactions (24).  Their ability to support highly specific protein-lipid 
interactions is dependent on the phosphate geometry at different locations 
on the inositol ring and can be differentiated with surprising precision (26, 
30).   
Several lines of evidence suggest that PtdIns(4,5)P2, plays a 
significant role in integrin regulation and the turnover of integrin complexes 
(31) (32).  Likewise, it has been suggested that an interaction between 
talin-1 and PtdIns(4,5)P2 directly competes with autoinhibitory interactions 
between the integrin binding FERM domain and its C-terminal rod domain 
(33). The talin FERM domain binds directly to the C-terminus of 
phosphatidylinositol-4-phosphate-5-kinase-γ (PIP5KIγ), a lipid kinase that 
generates PtdIns(4,5)P2 from PtdIns(4)P, suggesting that talin may recruit 
PtdIns(4,5)P2 to integrin signaling complexes.  However, PIP5KIγ 
knockout cell lines continue to support inside-out integrin activation, but 
exhibit loss of integrity under mechanical stress (34), suggesting that 
PtdIns(4,5)P2 may recruit secondary signaling molecules or simply 
reinforce talin-lipid interactions under mechanical shear.  
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Chapter 2  NMR analysis of the αIIb β3 cytoplasmic 
interaction suggests a mechanism for integrin 
regulation. 
 
Abstract 
 
The integrin αIIbβ3 is a transmembrane (TM) heterodimeric 
adhesion receptor that exists in equilibrium between resting and active 
ligand binding conformations. In resting αIIbβ3, the TM and cytoplasmic 
domains of αIIb and β3 form a heterodimer that constrains αIIbβ3 in its 
resting conformation.  To study the structure and dynamics of the 
cytoplasmic domain heterodimer, we prepared a disulfide-stabilized 
complex consisting of portions of the TM domains and the full cytoplasmic 
domains. NMR and hydrogen-deuterium exchange of this complex in 
micelles showed that the αIIb cytoplasmic domain is largely disordered, 
but it interacts with and influences the conformation of the β3 cytoplasmic 
domain. The β3 cytoplasmic domain consists of a stable proximal helix 
contiguous with the TM helix and two distal amphiphilic helices.  To 
confirm the NMR structure in a membrane-like environment, we studied 
the β3 cytoplasmic domain tethered to phospholipid bilayers. Hydrogen-
deuterium exchange mass spectrometry and circular dichroism 
spectroscopy demonstrated that the β3 cytoplasmic domain becomes 
more ordered and helical under these conditions, consistent with our NMR 
9 
 
results. Further, these experiments suggest that the two distal helices 
associate with lipid bilayers, but undergo fluctuations that would allow 
rapid binding of cytoplasmic proteins regulating integrin activation, such as 
talin-1 and kindlin-3.  Thus, these results provide a framework for 
understanding the kinetics and thermodynamics of protein interactions 
involving integrin cytoplasmic domains and suggest that such interactions 
may act in a concerted fashion to influence integrin stalk separation and 
exposure of extracellular ligand binding sites.   
I.  Introduction 
 
Integrins, ubiquitous heterodimeric adhesion receptors, reside on 
cell surfaces in equilibrium between resting low-affinity and active high-
affinity conformations. Interactions involving the transmembrane (TM) and 
cytoplasmic domains of integrin α and β subunits maintain the low affinity 
conformation, whereas intracellular signaling events disrupt these 
interactions, resulting in global conformational changes that activate the 
integrin (18). Following ligand binding, integrins cluster into complexes 
that initiate intracellular signaling pathways (35). 
On circulating platelets, the integrin αIIbβ3 is maintained in a 
resting conformation until platelets encounter vascular damage where it is 
rapidly shifted to its active conformation. This enables αIIbβ3 to mediate 
platelet aggregation by binding soluble ligands such as fibrinogen and von 
Willebrand factor (5). Activation occurs when intracellular proteins such as 
talin-1 and kindlin-3 bind to conserved motifs in the β3 cytoplasmic 
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domain, thereby disrupting TM and cytoplasmic domain heterodimers (19).  
It has been proposed that membrane-proximal αIIb and β3 cytoplasmic 
domain sequences form an activation-constraining “clasp”, featuring a 
salt-bridge between αIIb Arg995 and β3 Asp723 (36). However, studies 
specifically designed to detect this salt bridge have failed to do so (37).  
Although structures for the αIIbβ3 cytoplasmic domain heterodimer 
have been determined using soluble peptides and NMR, they may not 
reflect native contacts because they fail to account for constraining TM 
interactions (38, 39). To investigate the structure and dynamics of the 
cytoplasmic domain heterodimer as it exists in resting αIIbβ3, we 
covalently trapped the complex by introducing an inter-subunit disulfide 
bond near the C-terminal ends of the αIIb and β3 TM helices. The location 
of the crosslink was based on a computational model of the αIIbβ3 TM 
heterodimer (40).  While this work was in progress, three structures for the 
αIIbβ3 TM heterodimer plus short segments of the cytoplasmic domains 
were reported, confirming the model used to guide the introduction of the 
disulfide bond (15-17).  
We used NMR and hydrogen-deuterium exchange (HDX) mass 
spectrometry to study the structure and dynamics of the αIIbβ3 
cytoplasmic domain heterodimer in micelles and phospholipid bilayers. 
The αIIb cytoplasmic domain was largely disordered, but the β3 
cytoplasmic domain consisted of a proximal helix contiguous with the TM 
helix and two distal helices. The conformation of the proximal helix was 
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influenced by the presence of the αIIb cytoplasmic domain, whereas the 
conformations of the distal helices were similar to those observed 
previously in a monomeric protein corresponding to the β3 TM and 
cytoplasmic regions (37). Further, the distal helices were amphiphilic and 
likely lie along the inner surface of the platelet membrane. However, their 
interaction with the membrane is not so stable as to impede rapid binding 
of cytoplasmic proteins. Thus, our results provide a framework for 
understanding the kinetic and thermodynamic coupling between the 
cytoplasmic domains of integrins and intracellular signaling molecules, 
interactions that act in a concerted fashion to induce cytoplasmic and TM 
domain separation and the exposure of extracellular binding sites for 
integrin ligands.   
II.  Results 
Model αIIbβ3 cytoplasmic domain constructs. 
Figure 2.1A and 2.1B shows the sequences of the αIIbβ3 TM and 
cytoplasmic domains.  Our laboratory’s previous structural studies of the 
αIIbβ3 cytoplasmic domain focused on the lone β3 cytoplasmic domain in 
the absence of αIIb (Figure 2.1C) (37).  Given that integrin activation 
involves separation of the αIIb and β3 cytoplasmic domains, we reasoned 
that the structure of this construct would mimic that of the active integrin 
conformation.  In order to understand how αIIb and β3 might interact with 
each other in the inactive integrin state in which TM interactions place the 
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two cytoplasmic domains in close proximity, we designed a disulfide 
cross-linked NMR construct (Figure 2.1D).  Furthermore, to better under 
stand how the membrane environment might participate in the structure 
and dynamics of αIIbβ3, we designed two constructs for HDX analysis of 
the active and inactive αIIbβ3 conformations in the presence of 
phospholipid bilayers (Figure 2.1E and F). 
 
Figure 2.1 The sequences of the αIIbβ3  TM and cytoplasmic domains 
and experimental constructs used. 
 (A) The sequence of the β3 TM and cytoplasmic domains.  (B) The 
sequence of the αIIb TM and cytoplasmic domains. (C) The sequence of 
the previously reported (37) NMR construct containing the β3 TM and 
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cytoplasmic domains spanning from residue 691 to 762.  The N-terminus 
contains a Gly-Ser-Ala that remains from the thrombin cleavage site.  (D) 
The sequence of the NMR construct containing the αIIbβ3 cytoplasmic 
domains spanning from β3 residue 713 to 762 and αIIb residue 988 to 
1008. The β3 sequence contains an N-terminal His-tag as well as a Ser-
Pro-Glu helical cap.  The αIIb sequence contains an N-terminal Ser-Pro-
Glu helical cap.  (E) The sequence of the lipid-immobilized HDX construct 
containing the β3 cytoplasmic domain spanning from residue 720 to 762.  
It contains an N-termina Gly-Ser-His-Met-Gly from the thrombin cleavage 
site and the NdeI restriction site.  The β3 cytoplasmic domain was 
covalently attached to maleimide-functionalized phosphatidylethanolamine 
via a cysteine substitution at position 719. (F) The sequence of the bilayer-
tethered αIIbβ3 HDX construct spanning β3 residues 720 to 762 and αIIb 
residues 995 to 1008.  The αIIbβ3 heterodimer contains a disulfide cross-
link between β3 residue 719 and αIIb residue 954. The N-terminus of αIIb 
is functionalized with a myristoyl group for membrane immobilization.  {(C) 
made by RHL;  (D) made by DGM; (E) and (F) made by DTM} 
 
 
Our NMR construct (Figure 2.1D) contained the complete αIIb and 
β3 cytoplasmic domains plus a portion of their TM helices. The peptides 
were crosslinked by a disulfide bond between Cys residues replacing 
Met987 and Leu712 in the TM domains of αIIb and β3, respectively. The 
position for the disulfide bond was based on a model of the resting αIIbβ3 
TM heterodimer (41). Recently published NMR structural studies and 
disulfide crosslinking experiments confirm that a disulfide bond can be 
accommodated at this position with little change in backbone structure 
(15-17). For NMR experiments, the αIIb and β3 peptides were labeled 
biosynthetically with 13C and 15N in E. coli and disulfide-crosslinked after 
activating the β3 Cys with 2,2’-dithiobis(5-nitropyridine) (42).  The resulting 
disulfide-crosslinked construct migrated as a single species in 
polyacrylamide gels with an apparent molecular weight consistent with the 
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mass of the heterodimers. Following disulfide bond reduction, two 
peptides were observed that migrated with lower apparent molecular 
weights (Figure  2.2A).  
 
Figure 2.2 The αIIbβ3 cytoplasmic domain heterodimer construct 
before and after reducing its disulfide bond. 
The αIIbβ3 cytoplasmic domain heterodimer construct before and after 
disulfide reduction.  (a) Coomassie stained SDS-PAGE of the NMR 
construct.  Lane A, molecular weight markers.  Lane B, the disulfide-
crosslinked construct.  Lane C, the construct following disulfide bond 
reduction.  Differences in band intensity reflect differences in the 
molecular weights of αIIb and β3 peptides, the β3 peptide is three times 
larger than αIIb per mole. (b) Circular dichroism (CD) spectra of the αIIbβ3 
heterodimer before (solid line) and after reduction (dotted line). 
{Performed by DGM.} 
 
The NMR construct was not stable in the absence of detergents 
and when transferred to phospholipid bilayers resulted in precipitation of 
the mixture.  We reasoned that the NMR construct might be unstable in 
bilayers due to the incomplete TM domain, which would be unable to span 
the bilayer. Therefore two new constructs were designed for studies in the 
presence of phospholipids.  The intention of these constructs was to mimic 
15 
 
the αIIbβ3 cytoplasmic domain as it exited the bilayer.  The first construct 
was designed to model the active β3 cytoplasmic domain in the absence 
of αIIb.  In a recent disulfide crosslinking study (15) that mapped the 
interface between αIIb and β3 TM and membrane proximal regions, 
residue Ile719 was found to be the first β3 cytoplasmic residue to be 
accessible to chemical cross-linking, suggesting that it is accessible to the 
cytosolic compartment and likely at the membrane/cytosol interface.  
Ile719 was also predicted to be at the membrane/cytosol interface when 
the β3 TM and membrane proximal regions were modeled using the E(z) 
membrane insertion potential (43).  Based upon these findings, we 
reasoned that residue 719 would be appropriate for covalent attachment 
to the phospholipid headgroups.  To do so, we introduced a cysteine 
residue, which was reacted with the surface of bilayers containing 
maleimide-functionalized phosphatidylethanolamine (Figure 2.1E, top).  
The β3 cytoplasmic domain reacted readily with the bilayers and after two 
hours, only the immobilized construct was observed (Figure 2.3A).   
As for our NMR experiments, a disulfide cross-linked αIIbβ3 
construct was designed for HDX studies in the presence of bilayers.  
Besides placing Ile719 at the membrane surface recent disulfide cross-
linking studies (15) also found that position 719 was part of a helical 
interface between αIIb and β3.  In that study residue 719 readily formed a 
disulfide bond with position 994 in αIIb.  Using similar chemistry as for the 
NMR construct, the β3 cytoplasmic domain was attached to αIIb 
16 
 
cytoplasmic domain via a disulfide bond between residues 719 and 994 
respectively.  As disulfide chemistry was used to form the heterodimer, 
maleimide chemistry could not be used for immobilization on the 
membrane surface.  Instead, a myristoyl group was covalently attached to 
the N-terminus of αIIb.  The myristoylated αIIbβ3 construct was purified by 
HPLC (Figure 2.3B).   
 
Figure 2.3 Mass spectra of membrane tethered αIIbβ3 cytoplasmic 
domains. 
(A) The β3 cytoplasmic domain peptide (MW = 5680) containing an N-
terminal cysteine residue was reacted with large unilamellar vesicles 
(LUVs) for 1.5 hours at pH 6.8 producing the lipid conjugated β3 
cytoplasmic domain (MW = 6592).  MALDI-TOF mass spectrometry was 
performed on the starting material (bottom, magenta), the reaction after 30 
minutes (middle, green), and the reaction after 1.5 hours (top, blue). (B) 
Myristoylated-αIIbβ3 heterodimer was prepared as described in the 
methods, purified by HPLC, and subjected to MALDI-TOF mass 
spectrometry.  {Performed by DTM.} 
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Association of the αIIb and β3 cytoplasmic domains influences 
their conformation. 
Due to the inclusion of TM domain residues, the heterodimeric 
construct was insoluble in aqueous buffers and was studied in 
dodecylphosphocholine (DPC) micelles, similar to our previous analysis of 
the monomeric β3 TM and cytosolic regions (37). CD spectroscopy of the 
disulfide-linked construct contained bands at 190, 208, and 222 nm 
consistent with helical secondary structure (Figure 2.2B). Disulfide bond 
reduction resulted in a decrease in the magnitude of the molar ellipticity at 
222 nm, indicating that the disulfide-linked construct was more structured 
than its component monomers. 
The interface between αIIb and β3 was mapped by comparing 13C 
resonances of the disulfide-linked and monomeric peptides. Like the 
monomeric β3 cytoplasmic domain (37), Cα resonances of the β3 
cytoplasmic domain in the disulfide-linked construct were consistent with 
the presence of three helices: a proximal helix contiguous with the β3 TM 
domain (TMproxH) and two distal cytoplasmic helices (CytoH1 and 
CytoH2) (Figure 2.4A). No differences were observed between the distal 
helices of monomeric and disulfide-linked β3, but there were significant 
differences in the residues that define the proximal helix. The largest 
differences occurred at residues 720 through 724, eight to twelve residues 
downstream from the disulfide bond (Figure 2.4B), implying that the 
differences reflect αIIb and β3 interactions rather than local perturbations 
caused by the disulfide bond itself. Further, the chemical shifts are 
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indicative of increased helical content, consistent with the increased 
helical character in the CD spectrum following disulfide bond formation.  
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Figure 2.4  Interaction between αIIb and β3 cytoplasmic domains. 
(A) Cα chemical shifts define three helical regions of β3 in the disulfide-
linked heterodimer. Differences between the Cα resonances in the αIIbβ3 
heterodimer and β3 monomer are shown as bars above the graph. (B) 13C 
HSQC spectra of aliphatic atoms in the αIIbβ3 heterodimer (blue/purple) 
and the αIIb and β3 monomers (red and green). {Performed by DGM.} 
 
The 13C HSQC spectra of the disulfide-linked and reduced states 
were compared in order to determine the interface between the α and β 
chains (Figure 2.4B).  The chemical shifts of the Lys716 and Ile719 side 
chains changed when the disulfide bond was reduced, while no 
differences were observed for neighboring residues, suggesting that 
Lys716 and Ile719 interact directly with αIIb (further supporting the choice 
of disulfide cross-link in Figure 2.1F). Thus, Lys716 and Ile719 define a 
face of TMproxH that includes Asp723, a residue postulated to form a salt 
bridge with αIIb Arg995 (36).  Analysis of the Asp723 side chain neither 
confirmed nor refuted its interaction with αIIb. We did not identify NOEs 
between Arg995 guanidine protons and β3 sidechains. The Arg995 
resonances were characteristic of a dynamic side chain and did not 
change substantially when the disulfide bond was reduced. Further, NMR 
spectra and HDX results suggest that Asp723 and Arg995 are highly 
solvent-exposed. Thus, any acid/base interaction would appear to be 
dynamic and partially screened under physiological salt conditions.  
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Structure of the β3 cytoplasmic domain crosslinked to the αIIb 
peptide 
Three-dimensional structures were calculated for the αIIb and β3 
cytoplasmic domains using intra- and interchain NOEs, HN-Hα J-
couplings, and statistical analysis of chemical shifts (Figure 2.5A). We 
were unable to assign more than 5 strong NOEs between αIIb and β3, 
precluding calculation of a high-resolution structure. Moreover, the intra-
amide 1H-15N HSQC peak heights for αIIb became progressively greater 
from its N- to its C-terminus, implying that the αIIb cytoplasmic domain is 
largely unstructured near its C-terminus (Figure 2.6A). Thus, we focused 
on defining the structure of β3 in the presence of αIIb. A structure for β3 
was computed using 16 long-range, 235 medium-range, 259 short-range, 
and 202 intra NOE restraints, 84 dihedral angle restraints, and 24 
hydrogen bonds (Table S2.1). 
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Figure 2.5  The structure of the β3 cytoplasmic domain. 
(A) Twenty structures in the NMR ensemble, consisting of two regions 
encompassing residues Leu713-Trp739 and Asp740-Thr762, were aligned 
separately over well-ordered regions. Domains interacting with αIIb, talin-
1, kindlin-3, and c-Src are enclosed by dashed lines and side chains that 
make up interfaces are depicted as sticks. The two β3 NPXY motifs are 
colored magenta and the Src-binding RGT motif is colored cyan. (B) A 
single residue hinge at Arg724 is stabilized by packing between residues 
Ile721 and Phe727 (green) and an electrostatic interaction between 
Arg724 (blue) and Glu726 (red). (C) The first cytosolic helix (residues 
Glu726-Arg736) is stabilized by a network of complementary charged 
residues.  Positively charged residues are colored blue and negatively 
charged residues red.    {Structure solved by DGM.} 
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The C-terminal ends of TMproxH and CytoH1 pack together in a 
well-structured helix-turn-helix motif. Arg724 serves as a single-residue 
hinge between the two helices, having φ/ψ angles in the β/PPII region of 
the Ramachandran plot and producing a 100.5 ± 8.8° angle between the 
two helices.  A series of interactions, including strong NOEs between 
Phe727 and Ile721, as well as electrostatic interaction between Arg724 
and Glu726, stabilize the turn (Figure 2.5B).  CytoH1 itself is stabilized by 
a highly favorable arrangement of 12 intra-helical electrostatic interactions 
between residues i and i+3/4 (Figure 2.5C).  
CytoH1 is followed by a flexible linker spanning residues 738-743.  
CytoH2 is then initiated by Asn744, the first residue of an NPXY motif 
consisting of residues Asn744-Tyr747 (44, 45).  Although NPXY motifs are 
often found in β-turns, they are also helix initiation sites (46). Indeed, 
Asn744-Tyr747 adopts an identical conformation in a crystal structure of 
the F2F3 domains of talin-1 fused to a portion of the β3 cytoplasmic 
domain (pdb code 1MK7, chain A residues 744-747) (44). 
Conformational flexibility of the αIIbβ3 cytoplasmic domains in 
micelles 
 The dynamics of the cross-linked αIIb and β3 cytoplasmic domains in 
DPC micelles were studied by measuring the intensity of intra-amide 1H-
15N HSQC peaks (Figure 2.6A) (47, 48). αIIb residues Val990-Asn996 and 
β3 residues Leu713-Glu726, comprising the TM-proximal helices, 
displayed similar peak intensities, indicating limited mobility and stable 
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structures. β3 CytoH1 was somewhat more dynamic, while CytoH2 
showed graded mobility, becoming increasingly less structured near its C-
terminus.  As noted, 1H-15N HSQC peak intensities for αIIb became 
progressively greater near its C-terminus, implying that the terminal region 
of the αIIb cytoplasmic domain is largely unstructured.  These findings 
were confirmed by NMR measurements of amide proton exchange with 
solvent deuterons (HDX, Figure 2.6B) (49). Indeed, H-15N HSQC spectra 
of TMproxH were highly protected from HDX, while the distal helices 
exchanged in a rapid time regime that was not amenable to NMR studies. 
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Figure 2.6 Backbone dynamics of the αIIbβ3 cytoplasmic domain 
heterodimer. 
 (A) Backbone dynamics were inferred from intra-amide 1H-15N HSQC 
peak heights and were compared with the corresponding isolated 
β3 construct (37). (B) 15N HSQC spectrum of the disulfide-linked complex 
before and after HDX. The β3 backbone amides Ile714-Ile721 are 
protected from HDX, suggesting they form stable hydrogen bonds in a 
helix. Other helical regions exchange with deuterium on the minute time-
scale, suggesting they make excursions from helical conformations.  
{Performed by DGM} 
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Conformational flexibility of the αIIbβ3 cytoplasmic domain in 
phospholipid bilayers.   
Accordingly, we used mass spectrometry to measure HDX kinetics 
for the distal helices in phospholipid bilayer vesicles, a condition more 
closely resembling natural membranes than detergent micelles. This type 
of experiment has been used to determine membrane protein structure 
and measure unfolding rates (50, 51). We focused on the β3 segment 
spanning residue Thr720 to the C-terminus, because, as discussed above, 
this represents the portion of β3 accessible to the cytosolic compartment 
and the full-length NMR construct was not stable in bilayers.  The 
cytoplasmic domain was studied in aqueous solution as well as tethered to 
preformed large unilamellar vesicles (LUVs). As with our NMR studies, β3 
was probed in the presence and absence of αIIb in order to determine the 
effects of αIIb on its structure.   
CD spectroscopy revealed that when the β3 cytoplasmic domain 
was covalently tethered to bilayers, the peptide’s α-helical content 
increased and the random coil signature decreased (Figure 2.7), indicating 
that the β3 cytoplasmic domain interacts with phospholipid bilayers. To 
measure HDX, free and tethered β3 peptides were incubated in D2O buffer 
for varying periods of time, after which amide deuterium exchange was 
quenched at pH 2.5. The quenched peptides were injected onto an 
immobilized pepsin column to generate fragments that were analyzed by 
tandem LC/MS. Free β3 peptide exchanged rapidly with D2O (Figure 2.8, 
red), indicating that its conformation was largely disordered, consistent 
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with CD results (Figure 2.7).  When the β3 peptide was membrane-bound, 
the most membrane proximal region, Thr720-Glu732, remained tethered 
to the lipid after proteolysis and was not observed. However, we observed 
two fragments that contained portions of CytoH1 and CytoH2. Both 
fragments had two kinetically distinct classes of amides: one class had 
unprotected amides that exchanged at a rate indicative of an unstructured 
backbone; the second class exchanged with a protection factor on the 
order of 102 to 103, indicative of a helix making occasional excursions to 
less well-structured conformations that allow HDX.  The fragment 
containing the C-terminus of CytoH1, the flexible loop, and the N-terminus 
of CytoH2 (Glu733-Thr753) had approximately 8 protected amides (Figure 
2.8A, green).  The second fragment contained the C-terminus of CytoH2 
(Asn756-Thr762) and had only one protected amide (Figure 2.8B, green). 
These results confirmed the location of CytoH1, which was identified by 
NMR, as well as the hierarchy of increasing disorder that progresses from 
the N- to the C-terminus of the β3 cytoplasmic domain.   
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Figure 2.7 Circular dichroism confirms that interactions with 
phospholipids stabilizes a helical conformation. 
CD spectra were taken of free β3 in the absence of lipid (black dots), 
membrane- tethered β3 (solid line), and β3 mixed with lipids, but not 
reacted with the maleimide head group (grey dots and lines). CD spectra 
of β3 alone were taken of 30 µM β3 in 25 mM phosphate 100 mM NaCl, 
pH 6.8.  For lipid conjugated β3, 15 µM β3 was conjugated to 1 mM total 
lipid containing 20% POPG, 12% maleimide-PE,  and 68% POPC in 25 
mM phosphate with 100 mM NaCl, pH 6.8.  Unconjugated β3 in the 
presence of lipid contained 15 µM β3 and 1mM total lipid containing 20% 
POPG and 80% POPC.  {Spectra are representative of three independent 
experiments.  Performed by DTM] 
 
Our NMR results suggest that when αIIb is held in close proximity 
to β3 – as would be expected in the inactive αIIbβ3 conformation – a kink 
is stabilized in β3.  We hypothesized that such a kink would project distal 
β3 cytoplasmic elements such as CytoH1 and CytoH2 parallel to the 
membrane and encourage their interactions with the bilayer beyond the 
interactions observed with lipid-immobilized β3.  We therefore sought to 
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determine by HDX whether this kink in the presence of bilayers might 
stabilize distal structures observed by NMR.  As described above, we 
synthesized and purified a disulfide cross-linked αIIbβ3 construct with an 
N-terminal myristoyl membrane anchor.  This peptide was not water 
soluble, but was readily solubilized when extruded with phospholipid 
bilayers.  When HDX experiments were performed on this αIIbβ3 
construct, similar pepsin cleavage products were observed.  Again, the N-
terminus was not seen, because of its covalent attachment to αIIb, but 
peptides containing residues Glu733-Thr753 and the Asn756-Thr762 were 
observed.  Like β3 in the absence of αIIb (Figure 2.8A, green), the peptide 
spanning Glu733-Thr753 was found to have approximately 8 protected 
amides in the presence of bilayers (Figure 2.8A, blue).  The protection 
pattern for the most distal fragment was quite different, though.  The 
peptide containing Asn756-Thr762 was found to be significantly protected 
from exchange.  In the presence of bilayers, the heterodimeric αIIbβ3 
cytoplasmic domain had 3-4 amides with protection factors on the order of 
102-103 (Figure 2.8B, blue).  These results support the NMR-based model 
that the presence of αIIb stabilizes the interaction between β3 and the 
membrane.  It is possible that the protection of the distal β3 segment from 
HDX could arise from direct interactions with αIIb and as opposed to a 
helical interaction with the membrane, however, NOEs between αIIb and 
the β3 segment were not observed in the NMR.   
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Figure 2.8 HDX-MS of the αIIbβ3 cytoplasmic domain in phospholipid 
bilayers. 
Model αIIbβ3 cytoplasmic domain constructs were prepared in pH 6.8 
phosphate with 100 mM NaCl.  Each sample was diluted 1:10 in pH 6.8 
phosphate with 100 mM NaCl containing 90% D2O on ice.  Deuteration 
was quenched at pH 2.5 on ice and samples were injected onto a pepsin 
column in tandem with LC-MS to resolve fragments and calculate 
deuteration.  The deuteration reaction for each sample was fit to a double 
exponential rate equation assuming subpopulations of rapidly and slowly 
exchanging amides. Peptide fragments containing (A) Glu733-Thr753 and 
(B) Asn756-Thr762 were observed.  For each peptide a theoretical curve 
based upon the predicted intrinsic exchange rate for a disordered peptide 
was generated (black). HDX was performed on free β3 cytoplasmic 
domain (red), the β3 cytoplasmic domain covalently immobilized on 
phospholipid bilayers containing 20% POPG, 12% maleimide-PE, and 
68% POPC (green) which is predicted to model the active β3 state, and 
disulfide cross-linked αIIbβ3 in phospholipid bilayers containing 20% 
POPG and 80% POPC (blue) which is predicted to model the inactive 
state.  Residues highlighted in blue are predicted to be protected from 
exchange based upon the NMR structure.  Residues highlighted in orange 
correspond to regions found to be disorganized in the NMR structure or at 
the N-termini of helices and not predicted to be protected from exchange.   
{Experiments performed once by DTM} 
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The increased helicity of the β3 cytoplasmic domain (Figure 2.7) in 
the presence of bilayers and its protection from HDX under these 
conditions suggest that it interacts with the membrane surface. We used 
E(z), a depth-dependent potential (43), to assess the binding of the β3 
helices in membranes. As expected, TMproxH was predicted to partition 
into the bilayer perpendicular to the membrane as an extension of the TM 
helix, whereas CytoH1 and CytoH2 were predicted to lie along the 
membrane surface, stabilized by hydrophobic residues Phe727 and 
Phe730 in CytoH1 and Leu746, Tyr747, Ala750, Phe754, and Ile757 in 
CytoH2  (Figure 2.9A).    
III.  Discussion 
We have studied the structure and dynamics of the platelet integrin 
αIIbβ3 cytoplasmic domain. We found the αIIb cytoplasmic domain 
intrinsically disordered, consistent with its paucity of hydrophobic residues 
and a recent NMR study using phospholipids bicelles (52). Nonetheless, 
chemical shift perturbations indicate that αIIb interacts with the TM 
proximal portion of β3 over the length of 12 residues, implying that αIIb 
has a conformational bias toward structures that interact with β3. This type 
of intrinsically disordered interaction has been found in proteins that 
couple multiple signaling events to an overall equilibrium (53). In the case 
of αIIbβ3, an intrinsically disordered interface would allow the integrin to 
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rapidly shift between resting and active conformations following a breach 
in vascular integrity.  
The N-terminal portion of the β3 cytoplasmic domain consists of a 
highly stable helix contiguous with the C-terminal end of the TM helix and 
separated from a second surface-associated helix by a single-residue 
hinge at Arg724.  The remainder of the cytoplasmic domain consists of a 
short unstructured region, a second cytoplasmic helix and a flexible C-
terminal tail.  CytoH1 and CytoH2 are likely stabilized by interactions with 
the membrane bilayer (Figure 2.9A), although they are not so stable as to 
lock the cytoplasmic domain into a single fixed conformation. Instead, 
CytoH1 and CytoH2 undergo frequent excursions into non-helical 
conformations within the aqueous environment. The association of CytoH1 
and CytoH2 with membranes is consistent with previous NMR 
experiments observing NOEs between micellar DPC and Trp739/Tyr747 
(54). Amphiphilic domains proximal to TM domains have also been 
detected in proteins such as voltage gated channels (55, 56), 
phospholamban (57), and the influenza M2 proton channel (58, 59). The 
association of cytoplasmic helices with membranes can change in 
response to gating ligands or post-translational modification. For example, 
the cytoplasmic helix of the pH-activated M2 channel changes its 
orientation in response to pH. Also, aromatic residues in the cytoplasmic 
domain of the T-cell receptor CD3ε subunit were found to insert into 
membranes, including a tyrosine in its NPXY motif (60). Following T-cell 
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receptor activation, the amphiphilic domain is released from the 
membrane.  
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Figure 2.9 A linked equilibrium describing the activation of αIIbβ3 by 
intracellular signaling molecules. 
(A) The E(z) membrane insertion potential was used to model the 
interaction of β3 with the membrane.  It predicts that aromatic residues 
(green) on one face of CytoH1 and CytoH2 will preferentially bind the 
membrane. (B) The dynamic nature of the β3 cytoplasmic domain makes 
protein-protein interaction motifs accessible. Dissociation of αIIb and 
extension of the β3 TM-proximal helix to join CytoH1 allows talin-1 to bind 
and places positively-charged residues on talin-1’s upper surface in a 
favorable position to interact electrostatically with the inner membrane 
leaflet. β3 is also now available to bind kindlin.  Residues that are 
perturbed by the αIIb cytoplasmic domain are shown in red.  (C) An 
equilibrium model of talin-1 and kindlin-3 binding the integrin cytoplasmic 
domain.  To the left is a resting conformation with helices CytoH1 and 
CytoH2 interacting with the bilayer. The fully inactive state is not 
competent to bind talin-1 or kindlin-3 because the membrane obstructs 
access to β3. To the right is a fully active conformation with separated TM 
and cytoplasmic domains.  In between exists an ensemble of states in 
which the integrin is not active, but the β3 cytoplasmic domain samples a 
wide range of conformations and is accessible to intracellular molecules.  
Although talin-1 and kindlin-3 can bind the ensemble of free cytoplasmic 
domains in the middle column, available data are insufficient to predict the 
order of binding.  Therefore, equilibria depicting talin-1 binding first (top) 
and kindlin-3 binding first (bottom) are shown.  However the fact that both 
kindlin-3 and talin-1 are necessary for activation suggests that both bind to 
the integrin cytoplasmic domain.   
 
The marginally stable interactions between the membrane bilayer 
and the β3 cytoplasmic helices are likely important for allowing kinetic 
access to cytoplasmic proteins, such as talin-1 and kindlin-3, responsible 
for triggering αIIbβ3 activation (19). The structure of β3 elucidated here 
presumably represents the resting state which must undergo structural 
changes to allow binding of these proteins. The talin-1 binding site, 
extending from the C-terminus of the TM helix through CytoH1 to the 
NPxY motif near the N-terminus of CytoH2, is masked in the NMR 
structure by interactions with the αIIb tail and the phospholipid bilayer. 
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Interaction with membranes is facilitated by the bend between TMproxH 
and CytoH1 at Arg724; if this residue instead continues the TMproxH α-
helix (Figure 2.9B), CytoH1 becomes an extension of the TM helix, 
allowing binding of the talin-1 head domain (61, 62). This orientation not 
only allows interaction of the talin-1 F3 domain with the β3 tail, but also 
electrostatic interactions between acidic lipids on the cytoplasmic leaflet of 
the bilayer and positively charged residues in talin-1’s F2 and F3 domains.  
Moreover, the interaction of the β3 tail with talin-1 removes the C-terminal 
region of β3 from the membrane and positions its kindlin-binding site for 
simultaneous interaction with kindlin-3.  Such a tandem interaction has 
recently been demonstrated for dimerization of the PTB domain of the 
cytoplasmic adaptor protein Dok7 (63). Displacement of this segment from 
the membrane also destabilizes the C-terminal β3 helix, allowing it to more 
easily conform to the requirements for kindlin-3 binding. 
The interactions of talin-1 and kindlin-3 with β3 show the hallmarks 
of a cooperative system; association of either protein with its β3 binding 
site occurs at the thermodynamic expense of disrupting favorable β3-
membrane binding interactions. Moreover, binding of one protein primes 
the system for a more favorable interaction with the second. Thus, the 
sites are both kinetically and thermodynamically linked, as shown in 
Figure 2.9C. The talin-1 binding event is likely the key step in tail 
separation, given the proximity of the talin-1 interacting site to the αIIbβ3 
interface. Thus, at sufficiently high talin-1 concentrations, it should be 
37 
 
possible to activate αIIbβ3, even in the absence of kindlin-3 (64). 
However, under physiologic conditions, our model predicts that kindlin-3 
also plays a pivotal role for interaction of talin-1 with the β3 tail. At present, 
it is unclear whether there is a preferred temporal sequence for binding of 
kindlin-3 versus talin-1 during physiological αIIbβ3 activation. However, 
the greater mobility of the kindlin-3 binding site in the β3 cytoplasmic 
domain suggests it might have a kinetic advantage over talin-1, assuming 
both are present in appropriate forms for binding.  Figure 2.9C (top and 
bottom) illustrates both kinetic possibilities for the initial binding step. Once 
initial binding occurs, subsequent interactions and conformational changes 
become increasingly favorable, ultimately tipping the equilibrium towards 
tail separation and αIIbβ3 activation (Figure 2.9C, middle panel). This 
thermodynamic coupling model could be extended to any number of 
cytoplasmic events playing negative or positive roles in activation. We 
predict that direct interactions of the β3 cytoplasmic domain with αIIb and 
the phospholipid bilayer help restrain αIIbβ3 in a resting state.  Any protein 
that binds more tightly to the separated cytoplasmic domains than the 
cytoplasmic domain heterodimer will have an activating effect. 
Furthermore, proteins that negatively impact talin-1 binding will have an 
inhibitory effect on αIIbβ3 activation.  
IV. Methods 
Plasmid Constructs—A cDNA encoding αIIb residues Trp988-
Glu1008 was cloned into the vector pET-16b (Novagen) as a C-terminal 
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fusion with the designed protein α3D (65). The region between the αIIb 
sequence and α3D included a proline to disrupt secondary structure, two 
glycines as a flexible spacer, a thrombin cleavage site, an SPE N-terminal 
helix cap, and a cysteine for crosslinking to the β3 peptide.  The αIIb 
peptide sequence was: α3D-P-GG-LVPR-SPE-C-
WKVGFFKRNRPPLEEDDEEGE. A cDNA encoding β3 residues Leu713-
Thr761 was cloned into the vector pET-15b (Novagen) downstream from a 
polyhistidine tag. The construct included an SPE N-terminal helix cap 
followed by a cysteine for crosslinking.  The β3 peptide sequence was: 
MGSSHHHHHHSSGLVPRGSHM-SPE-C-
LIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT. 
The fidelity of the constructs was confirmed by DNA sequencing. 
A shortened β3 cytoplasmic domain 
(MGSSHHHHHHSSGLVPRGS-|-H 
MG-C-TIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT) 
was cloned into the pet-28a vector.  It contained a cysteine for reaction 
with phospholipid bilayers or αIIb.   
Protein Expression and Purification—The α3D-αIIb fusion protein 
and the His-tagged β3 protein were expressed in E. coli strain BL21 and 
labeled biosynthetically with 13C glucose and/or 15N ammonium chloride 
(Cambridge Isotope Laboratories).  The α3D-αIIb fusion protein was 
isolated from the supernatant of bacterial lysates, cleaved with thrombin, 
and purified by reverse-phase HPLC.  The His-tagged β3 protein was 
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isolated on Ni-NTA resin using the QIAExpressionist protocol for 
denaturing conditions (Qiagen) and purified by reverse-phase HPLC.  
These protocols generated >10 mg of the αIIb and β3 proteins per liter 
culture.  The molecular weight of each product was confirmed by mass 
spectroscopy. 
The His-β3 construct used for HDX was expressed in BL21-DE3 E. 
coli and purified using Ni-NTA chromatography on an Akta FPLC (General 
Electric Healthcare).  Purified His-β3 was dialyzed into 50mM Tris, 100 
mM NaCl, pH 7.5 and cleaved with thrombin overnight at room 
temperature.  The resulting peptide (GSHMG-C-
TIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT) was 
purified by reverse phase HPLC on a C4 preparative column (Vydac) on a 
water/acetonitile/iPrOH gradient in 0.1% TFA.   
 
SDS-PAGE of αIIbβ3 NMR construct-The disulfide cross-linked 
heterodimer was dissolved in LDS loading buffer and run on a NUPAGE 
SDS-PAGE gel.  Excess TCEP was added to an identical sample and run 
in an adjacent lane.  The gel was washed and stained with Coomassie 
GelCode stain (Pierce). 
 
 Synthesis of the myristoylated αIIb cytoplasmic domain–αIIb-CT 
was synthesized on Wang resin preloaded with an Asp residue using a 
Symphony peptide synthesizer at 0.1 mM scale in 25% DMSO/75% NMP 
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with Fmoc-chemistry. αIIb-CT was myristoylated on resin by reacting the 
protected peptide with 5-fold excess HBTU activated myristic acid (Sigma) 
for three hours at room temperature. αIIb-CT was cleaved from the resin 
TFA/triethylsilane/water (95/2.5/2.5 v/v) for three hours and precipitated 
into dry-ice cold diethylether. β3-NITYRGT was purified by reverse phase 
HPLC (Varian Prostar) using a C4 preparative column (Vydac) on a 
water/acetonitrile/iPrOH gradient with 0.1% TFA.   
 Formation of a disulfide-linked αIIbβ3 cytoplasmic domain 
heterodimer for NMR—The β3 peptide was dissolved at 5 mg/ml in 50 mM 
MES buffer, pH 6.0, containing 2M guanidine, after which its cysteine thiol 
was activated with a 5-fold molar excess of 2-2'dithio-bis-(5-nitropyridine) 
dissolved in DMSO (42). After excess 2-2'dithio-bis-(5-nitropyridine) was 
removed on a PD-10 column (GE Healthcare), the activated β3 was 
reacted with a slight molar excess of the αIIb protein in guanidine-MES 
buffer, pH 6.5. Disulfide-linked αIIbβ3 was purified using reverse phase 
HPLC in a gradient with 60% iPrOH, 30% ACN, 10% H2O with 0.1% TFA. 
Its molecular weight confirmed by mass spectrometry. 
Preparation of a disulfide-linked membrane-tethered αIIbβ3 
cytoplasmic domain heterodimer for HDX.  The β3 cytoplasmic domain 
was prepared as described earlier. To form the myristoylated αIIbβ3 
heterodimer, the β3 cytoplasmic domain was reacted with 2-2'dithio-bis-(5-
nitropyridine) in 50% acetic acid to produce activated 2-thio-(5-
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nitropyridine) adduct, which was transferred to pH 5 sodium acetate buffer 
and separated from unreacted 2-2'dithio-bis-(5-nitropyridine) by passage 
over a PD-10 buffer exchange column (GE Healthcare).  The activated β3 
was diluted nine fold with acetonitrile and reacted with a slight excess of 
Myr-αIIb.  It was crucial to perform this reaction in an organic solvent, as 
Myr-αIIb homodimers were the primary product in aqueous buffers, likely 
due to formation of micelles or aggregates due to the myristic functional 
group that produced a high local concentration of Myr-αIIb thiol that 
displaced β3 from the αIIbβ3 heterodimer.  The reaction was diluted with 
pH 2 water and immediately frozen and lyophilized for purification by 
reverse phase HPLC on a gradient with 60% iPrOH, 30% ACN, 10% H2O 
with 0.1% TFA.   
Preparation of membrane tethered β3. Lyophilized Cys-β3 
construct was lyophilized and re-dissolved in bilayer conjugation buffer 
(25mM sodium phosphate or MOPS, 100 mM NaCl, pH 6.8).   Large 
unilamelar vesicles (LUVs) were generated by evaporating a mixture of 
20% 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG, 
Avanti Polar Lipids), 4 fold molar excess of 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-
carboxamide] (16:0 PE MCC, Avanti Polar Lipids) relative to β3 peptide, 
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti 
Polar Lipids) to a thin film under nitrogen and re-suspending the dried 
lipids in the bilayer conjugation buffer.  LUVs were prepared by extruding 
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20 times through a 0.1 µm filter (Avanti Polar Lipids).  β3 peptide was 
reacted with 4 fold molar excess 16:0 10 PE MCC.  The conjugation 
reaction was performed at pH 6.8 to minimize lysine amine-maleimide side 
reaction which is strongly disfavored at below pH 7.  
NMR Spectroscopy—Purified, disulfide-linked αIIbβ3 heterodimer 
was dissolved at 1 mM in 5 mM sodium phosphate buffer, pH 6.0, 
containing 100 mM perdeuterated DPC (Cambridge Isotope Laboratories), 
10% deuterium oxide, and 0.02% sodium azide. Samples were analyzed 
at 37ºC on a 750 MHz NMR spectrophotometer equipped with a Varian 
probe (66).    
CD spectroscopy for the NMR sample—CD spectra of 10 µM 
disulfide-linked αIIbβ3 heterodimer in 5 mM sodium phosphate buffer, pH 
6.5, containing 10mM dodecylphosphocholine (DPC) were collected on a 
JASCO J-810 spectropolarimeter with a path length of 1 mm before and 
after the addition of a 5-fold molar excess of the reducing agent tris(2-
carboxyethyl) phosphine hydrochloride (Sigma-Aldrich). Measurements 
were made stepwise for each 1 nm between 190 nm to 260 nm and 
averaged over ten scans. 
Assignment of chemical shifts—The backbone, aliphatic, and 
aromatic resonances in the αIIb and β3 subunits were assigned using a 
standard battery of experiments.(66)  Complete residue-specific 
assignments for the Hα, N, Cα, and Cβ resonances in β3 were obtained 
using the HNCACB(67) and CBCA(CO)NH(68) experiments.  Carbonyl 
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carbons were assigned from HNCO experiments.(69)  Aliphatic protons 
and carbons were identified using H(CCCO)NH,(70, 71) 
(H)CC(CO)NH,(70, 72, 73) and H(C)CH-TOCSY(74-77) experiments.  
Pro-chiral leucine and valine methyls were distinguished in the 13C-
coupled carbon HSQC of a metabolically labeled sample expressed in 
media containing 10% 13C glucose.(78)  Aromatic resonances were 
assigned using HBCBCGCDHD and HBCBCGCDCEHE experiments,(79) 
an aromatic carbon HSQC, an aromatic 13C-edited NOESY, and other 
NOESY experiments.  Assignments for αIIb residues 988-1000 were 
completed using the same strategy.  Additionally, resonances in the αIIb 
acidic tail E1001EDDEEGE1008 were identified, but were not useful for 
structural analysis due to spectral overlap. Proton chemical shifts were 
referenced to residual water signal, while 13C and 15N chemical shifts were 
indirectly referenced. Chemical shifts were deposited in the 
BioMagResBank (80). 
Identification of NOEs—Nuclear Overhauser Effect restraints 
(NOEs) were obtained from an 15N-editied NOESY, an aliphatic 13C-edited 
NOESY, an aromatic 13C-edited NOESY, and a 4D 13C-edited 
NOESY.(81, 82)  Mixing times were optimized for different NOESYs and 
ranged from 80 ms in the 13C-edited NOESYs to 100 ms in the 15N-editied 
NOESY.  The solvent contained 99% D2O in the 4D NOESY. 
HN-Hα J-coupling—Phi dihedral angle restraints were obtained 
from HN-Hα J-couplings measured in the HNHA experiment.(81)  Phi 
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angles were calculated using the Karplus equation with coefficients A = 
6.51, B = -1.76, and C = 1.60.  β3 residues Lys716-Thr720, Phe727-
Arg736, and Leu746-Asn756 were given helical phi restraints based on 
chemical shift analyses, NOE patterns, and HDX experiments that suggest 
they reside in helices.  Other residues were given J-coupling restraints 
that restrict the phi dihedral to 1-4 possible angles. 
Hydrogen-deuterium exchange (HDX)— HDX was performed by 
lyophilizing a NMR sample and re-dissolving it in deuterium oxide.  
Exchange was monitored in the HSQC experiment and the first time-point 
was taken at 11 minutes. 
Residual dipolar couplings (RDCs)— RDCs were obtained for 
samples aligned in axially stretched polyacrylamide gels.  A dried, 6mm 
diameter, 5.5% polyacrylamide gel was soaked with an NMR sample for 
72 hours, then funneled into a 4.2mm diameter NMR tube.(83)  Cα-C’ 
RDCs were obtained using a Cα-coupled HNCO experiment.(69)    
Implementation of distance restraints—Distance restraints were 
derived from NOE experiments and HDX. NOESY cross-peak volumes 
were converted to upper distance limits by the program CALIBA of the 
CYANA package (84).  NOE peaks were divided into three classes with 
different calibration functions and constants: a 1/r6 dependence was used 
for backbone-proton-backbone-proton NOE values, and a 1/ r4 
dependence for NOEs involving side-chain protons and methyl groups. 
The upper and lower cutoffs for NOEs before application of pseudoatom 
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corrections were set as 2.4 and 6.0 Å for strong and weak NOEs, 
respectively. During the structure calculation and NOE assignment, the 
calibration curves were refined iteratively based on plots of cross-peak 
volumes versus average proton-proton distances in the current structures.  
For each distance constraint, the lower limit was set as 1.8 Å, which 
corresponds to two hydrogen van der Waals radii.  Additionally, 24 
hydrogen bonds were used for the regular secondary elements Glu711-
Asp723, Glu726-Ala736, and Pro745-Ile758.  5 hydrogen bond restraints, 
which were also confirmed from HDX, were implemented by setting the N 
to i+4 O distance to 3.0 Å with 10% error, while the remaining hydrogen 
bond restraints were held with 20% error.  
Implementation of angle restraints—Dihedral angle restraints were 
derived from TALOS+(85) (86) and J-coupling experiments.(81)  The 
TALOS algorithm predicts backbone phi and psi angles based on protein 
sequence and assigned resonances from a database of known structures.  
TALOS-derived phi and psi dihedral restraints were used for β3 residues 
Cys712 - Thr758, except for residues Arg724, Lys738 and Trp739, which 
were predicted to be helical with high confidence, consistent with NOE 
patterns, HDX, and J-coupling.  Additionally, phi dihedral angle restraints 
were obtained from HN-Hα J-couplings.  β3 residues Leu713-Asp723, 
Glu726-Arg736, and Pro745-Thr758 were given helical phi and psi angle 
restraints based on chemical shift analysis, NOE patterns, and HDX 
experiments which suggest they reside in helices.  Other residues were 
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given J-coupling restraints that restrict the phi dihedral to 1-4 possible 
angles.(81) 
Implementation of RDC restraints—RDCs were measured and 
evaluated. Nonetheless, the dynamics of the αIIbβ3 construct prevented 
fruitful refinement of the structural ensemble using RDCs. 
Structure Calculation—Data were processed with FELIX, analyzed 
with Sparky and Xeasy (87) , and structures were calculated using 
CYANA (84) and finally refined by XPLOR-NIH.(88)  Structure calculations 
and refinement algorithms were based on the anneal.py and refine.py 
example scripts that come with the XPLOR-NIH package.  Structures were 
calculated for the β3 portion of the disulfide linked αIIb/β3 construct 
consisting of the SPE N-terminal helix cap, the cysteine used to form the 
disulfide crosslink, and β3 residues 713-762:  
SPE-C-
LIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT 
where the italicized residues were engineered and the rest of the construct 
corresponds to the β3 cytosolic domain.  Each algorithm included an 
initial, high temperature simulated annealing cycle followed by a longer 
simulated annealing cycle with both cycles restricted to torsional 
movements.  After the simulated annealing cycles, the output 
conformation was minimized in both torsional and Cartesian space.  The 
energy function included a repulsive van der Waals term and potentials 
that enforced bond lengths, bond angles, and improper angles.  
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Additionally, the refinement algorithm included a potential that enforced 
backbone geometries that are consistent with Ramachandran space.  
Other potentials enforced NMR restraints as described below. 
No violations >0.5 Å per conformer were observed. The statistics of the 
structure determination are summarized in Table S2.1 and show that a 
high-resolution and high-quality structure was obtained. The final structure 
was deposited in the PDB(89) (accession code: 2KV9). 
Calculation of a structural ensemble for the β3 cytoplasmic 
domain—NOE distance restraints were derived from a 3D 15N-edited 
NOESY, 3D aliphatic 13C-edited NOESY, 3D aromatic 13C-edited NOESY, 
and a 4D 13C-edited NOESY (75). Hydrogen bonding distances and 
geometry restraints (90) were implemented for the backbone amides of 
the β3 regions Glu711-Asp723, Glu726-Ala736, and Pro745-Ile758, 
predicted to reside in α-helices based upon NOEs and TALOS+. The φ 
and ψ dihedrals of β3 residues Cys712-Thr758 (excluding Arg724, Lys738 
and Trp739) were restrained based on a statistical analysis of chemical 
shifts using the TALOS+ algorithm (85). Structures were calculated using 
CYANA (84) and refined with XPLOR-NIH using a protocol similar to the 
anneal.py and refine.py example scripts that come with the software 
package (88, 91). A summary of the structural restraints is reported in 
Table S2.1.  
Circular Dichroism (CD) spectroscopy of lipid-conjugated β3.  CD 
spectra were taken on a JASCO J-810 spectropolarimeter.  15 µM β3 was 
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conjugated to 1 mM total lipid and probed in 25 mM phosphate with 100 
mM NaCl, pH 6.8.  Spectra of free β3 were obtained of 30 µM β3.  
Measurements were made stepwise for each 1 nm between 200 nm to 
240 nm and averaged over three scans. 
Pepsin-LC-MS/MS HDX.  A stock solution consisted of 15 µM β3 
peptide or β3 peptide conjugated to lipid in 25 mM phosphate and 100 mM 
NaCl, pH 6.8.  H-to-D exchange was initiated by diluting 5 or 10 µL of 
peptide stock solution into 15 or 10 µL of deuterated buffer, respectively.  
The reaction mixtures were then incubated for 10 seconds to 1.4 hours, as 
were non-deuterated control samples.  Peptides fragments were collected 
on a reverse phase trap column (4 µL bed volume, ExSAR) for 3 min.  
Peptide fragments were eluted from the trap and separated 
chromatographically on a reverse phase column (4 µL bed volume, 
ExSAR) using a linear HPLC gradient of 12% to 45% acetonitrile over 11 
minutes (pH 2.5, 0°C) at a 6 µL/min flow rate.   Peptides were ionized by 
ESI for mass spectrometric analysis in a Thermo Fisher OrbiTrap-LTQ.  
Resulting mass spectra were analyzed using the DXMS software 
package (Sierra Analytics).  The deuterium values per peptide were 
corrected for the deuterium content in the reaction conditions, as well as 
for deuterium loss in liquid handling by assuming an average of 75% 
deuterium recovery.   Intrinsic exchange curves were generated using 
HXpep (92).  Experimental curves were generated from the exchange 
rates generated by exponential fitting of intrinsic curves.  Fitting of the 
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experimental curves gives the slowing factor, which is a measure of the H-
to-D exchange protection when compared to a random coil structure.  
 
Supplemental 
 
 
Table S2.2.1 Summary of β3 structure statistics 
Conformationally restricting distance constraints  
Intraresidue [i = j] 202 
Sequential [|i – j| = 1] 259 
Medium Range [1 < |i – j| < 5] 235 
Long Range [|i – j| => 5] 
  16 
Total  712 
Dihedral angle constraints  
ϕ 42 
ψ 42 
Hydrogen bond restraints 24 
Average number of constraints per residue 15.2 
Average number of distance constraints violations per 
Xplor-NIH conformer 
 
> 0.5 Å 0 
Average number of dihedral-angle constraint violations 
Xplor-NIH conformer 
 
> 5° 0 
Average r.m.s.d. to the mean coordinates [Å]  
Residues 713-723 and 726-736, backbone heavy 
atoms 
0.68 ± 0.25 
Residues 713-723 and 726-736, all heavy atoms 1.56 ± 0.27 
Residues 713-723,726-736 and 745-758 , backbone 
heavy atoms 
4.63 ± 1.37 
Residues 713-723,726-736 and 745-758, all heavy 
atoms 
5.27 ± 1.46 
PROCHECK(93) G-factors Z-score for all residues (ϕ and 
ψ / all dihedral angles) a  
2.08 / 1.89 
PROCHECK(93) G-factors Z-score for ordered residues (ϕ 
and ψ / all dihedral angles) b 
2.68 / 2.60 
MOLPROBITY(94) clash Z-score 
 (all residues a / ordered residues b) 
-1.18 / -1.18 
Ramachandran plot summary [%] (all residues a / ordered 
residues b) 
 
most favored regions 90.8 / 94.5 
Additionally allowed regions   7.8 /   5.2 
generously allowed regions   1.1 /   0.3 
disallowed regions   0.3 /   0.0 
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a
 Residues 709 - 762 
b
 Residues 711-735, 738-758 
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Chapter 3 The affinity of talin-1 for the β3-integrin 
cytosolic domain is determined by its phospholipid 
bilayer environment. 
Abstract 
Binding of the talin-1 FERM domain to the β3 cytosolic tail causes 
activation of the integrin αIIbβ3. The FERM domain also binds to acidic 
phospholipids.  Although much is known about the interaction of talin-1 
with integrins and lipids, the relative contribution of each interaction to 
integrin regulation and possible synergy between them remain to be 
clarified. Here, we examined the thermodynamic interplay between FERM 
domain binding to phospholipid bilayers and to its binding sites in the β3 
tail. We found that although both the F0F1 and F2F3 subdomains of the 
talin-1 FERM domain bind acidic bilayers, the full-length FERM domain 
bound with an affinity similar to F2F3, indicating that F0F1 does not 
significantly increase the affinity for the membrane.  When free in solution, 
the β3 tail has weak affinity for the FERM domain. However, appending 
the tail to acidic phospholipids increased its affinity for the FERM domain 
by three orders of magnitude. Nonetheless, the affinity of the FERM for 
the appended tail was similar to its affinity for binding to bilayers alone. 
Thus, talin-1 binding to the β3 tail is a ternary interaction dominated by a 
favorable surface interaction with phospholipid bilayers and set by lipid 
composition. Nonetheless, interactions between the FERM domain, the β3 
tail, and lipid bilayers were not optimized for a high-affinity synergistic 
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interaction, even at the membrane surface. Instead, the interactions 
appeared to be tuned in such a way that the equilibrium between inactive 
and active integrin conformations can be readily regulated.  
 
I.  Introduction 
 
 
The integrin αIIbβ3 resides on the platelet surface in equilibrium 
between resting and active conformations (5, 6, 95-97). On circulating 
platelets, αIIbβ3 is constrained in its inactive conformation to prevent 
spontaneous platelet aggregation. Similarly, the cytoskeletal protein talin-
1, whose binding to the β3 cytosolic tail (CT) stabilizes the active 
conformation of αIIbβ3 (98-100), is sequestered away from the β3 CT 
(101). Besides interacting with integrins, talin-1 interacts with negatively-
charged phospholipids (102-104) and phosphoinositides (31, 33, 105, 
106). Stimuli generated at sites of vascular damage recruit talin-1 to the 
platelet plasma membrane, thereby promoting αIIbβ3 activation (12, 19). 
Much is known about the interaction of talin-1 with integrins and lipids, but 
the relative contribution of each interaction to integrin regulation and 
possible synergy between them remain to be clarified. Elucidating these 
interactions is important for understanding events leading to and 
controlling the formation of integrin complexes and for potential 
pharmacologic modulation of integrin signaling.  
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Talin-1 is a 250 kD protein containing a 45 kD N-terminal head 
domain attached via a flexible linker to a 200 kD C-terminal rod domain 
(99). Because the head domain is packed against the rod domain in its 
inactive state (107), talin-1 recruitment to the membrane and to integrin 
β CTs requires disruption of this interaction (108). At integrin-mediated 
cellular adhesions, the orientation of talin-1 is highly polarized, with its 
head domain associated with the plasma membrane and its rod domain 
making numerous cytoskeletal contacts (108).  
The talin-1 head domain is a member of the FERM 
(4.1/Ezrin/Radixin/Moeisin) domain family (109, 110). Canonical FERM 
domains, such as that of radixin, consist of F1, F2, and F3 subdomains 
adopting ubiquitin, acyl-CoA-binding protein, and PTB/PH domain folds, 
respectively, and are assembled into a trefoil arrangement (Figure 3.1 A 
and B). The talin-1 FERM domain contains a fourth subdomain, F0, 
preceding F1 that also adopts a ubiquitin-like fold (111). The four talin-1 
subdomains have an extended, nearly linear, configuration (PDB code 
3ivf, Figure 3.1C) (104). Whereas radixin binds its targets, such as the 
CD44 CT, in a groove formed by helix α1 and strand β5 of its F3 
subdomain in an anti-parallel β-β fashion (Figure 3.1A), the talin-β integrin 
CT complex contains a second interface with the N-terminal helical portion 
of the CT (Figure 3.1D) (61, 112). This positions talin to modulate 
interaction between membrane-proximal cytosolic and transmembrane 
segments of integrin α and β subunits (1, 61, 112).   
54 
 
 
Figure 3.1 Comparison of the Talin-1 and Radixin FERM domains. 
 (A) The radixin FERM domain is composed of three subdomains: F1 (left, 
orange), F2 (center, yellow), and F3 (right, green).  The CD44 cytoplasmic 
tail (blue) binds to a cleft in F3 formed by helix α1 and strand β5.  (B)  The 
radixin subdomains adopt a canonical trefoil shape. (C) The talin-1 FERM 
domain contains F1 (orange), F2 (yellow), and F3 (green) domains, as 
well as an F0 subdomain (red) that precedes F1.  Instead of a trefoil, the 
talin-1 FERM subdomains are arrayed linearly. (D) Model of talin-1 F3 
(green) bound to the integrin β1D CT (black). Two regions of the β1D CT 
interact with talin-1 F3: its C-terminal portion adopts an extended 
conformation and packs against a ridge formed by the interface of helix α1 
and strand β5 in F3, while an N-terminal α-helix and a contiguous portion 
of the β1 transmembrane (TM) domain packs against the top of F3.  
Radixin structures were generated from PDB 2zpy.  Talin-1 structures 
were modeled using PDB 3g9w and PDB 3ivf.      
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Here, we examine the thermodynamic interplay between 
phospholipid bilayers and β CT binding sites in the talin-1 FERM domain. 
The impetus for this study arose, in part, from conflicting findings 
regarding the ability of the talin-1 FERM domain to interact with the β3 CT. 
In solution, the affinity of talin-1 for β integrin CTs is nearly 1000-fold 
weaker than the affinity of radixin for CD44 (113) or of talin-1 for the C-
terminus of PIP5KI-γ (61). However, talin-1 binds to the β3 CT with high 
affinity when the CT is immobilized on a carboxy-methylated dextran 
surface (114). This suggests that the interaction of talin-1 with integrins is 
optimal when the β subunit CT is presented on a hydrophilic negatively-
charged surface such as the inner leaflet of plasma membranes.   
To assess the interplay between membrane and β CT binding 
interactions, we tested whether the talin-1 FERM subdomains F0F1 and 
F2F3  (Figure 3.2B and C), each of which can interact with membranes 
(111), bind cooperatively or independently to a variety of negatively 
charged lipids and compared their binding to the complete FERM domain 
(F0-F3, Figure 3.2A).  We then measured the effect of the membrane 
environment on the affinity of FERM domain binding to the β3 CT. We 
found that although the membrane environment increased the overall 
affinity of the FERM domain for β3, the interactions between the FERM 
domain, the β3 CT, and lipid bilayers were not optimized for a high-affinity 
synergistic interaction, even at the membrane surface. Instead, the 
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interactions appeared to be tuned in such a way that the equilibrium 
between inactive and active integrin conformations can be readily 
regulated.  
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Figure 3.2 Talin-1 and αIIbβ3 constructs used. 
Talin-1 constructs encompassing the (A) F0, F1, F2, and F3 subdomains, 
(B) the F0 and F1 subdomains, and (C) the F2 and F3 subdomains.  Each 
construct contains an N-terminal Gly-Ser-His-Met (GSHM) motif enabling 
cleavage by thrombin.  (D)  β3 CT constructs include the entire CT 
including the talin-1 recognition motif (bold) and preceded by a Cys 
residue at position 719 as well as an N-terminal GSHMG sequence for 
cleavage by thrombin (top); a fluorescent β3 CT construct in which a 
maleimide-BODIPY-TMR moiety is appended to C719 (middle); and a β3 
CT construct in Cys719 was covalently modified with maleimide-
functionalized phosphatidylethanolamine (bottom).  (E) FITC-labeled 
peptide derived from PIP5KIγ.  {All talin and integrin constructs cloned, 
expressed, and purified by DTM.  PIP5K1γ was synthesized by HJ.} 
II.  Results 
The talin-1 FERM domain contains an extended positively-
charged surface.   
Projection of an electrostatic surface on the talin-1 FERM domain 
revealed that it contains an extended positively-charged surface (Figure 
3.3) (104). This is especially pronounced for the F2 and F3 subdomains.  
The F0 and F1 subdomains also contain positively charged surfaces and 
F1 contains a flexible loop that readily binds to membranes but was 
removed for crystallization (107). The positively-charged surfaces on F0F1 
are not completely aligned with those on F2F3. Although this could reflect 
a strong bias for maintaining the surfaces in an unaligned state in solution 
or the selection of a single conformation from a flexible ensemble due to 
crystal packing, X-ray scattering studies argue against a flexible ensemble 
of structures (104). Thus, if the solution conformation is maintained, F0F1 
should make only modest contributions toward the affinity of the overall 
complex over that of the F2F3 alone.  Alternatively, if F0F1 and F2F3 
change their mutual orientation away from the minimum energy solution 
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conformation, this would attenuate the affinity relative to the value 
expected if they were pre-organized to interact favorably with the surface.    
 
Figure 3.3 Orientation of the talin-1 FERM domain with respect to the 
inner leaflet of the plasma membrane. 
As in Figure 3.1, the talin-1 F0-F3 subunit bound to a β-integrin was 
modeled using the crystal structure of the talin-1 FERM domain (pdb code 
3ivf). (A) The interaction of talin-1 with the β integrin CT (black) places its 
FERM domain in proximity to the inner plasma membrane leaflet.  (B) 
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Projection of an electrostatic surface onto the talin-1 FERM domain. Red 
denotes negative and blue denotes positive-charge density.  (C) Talin-1 
FERM domain rotated 90° showing the electrostatic surface as viewed 
from the membrane (left) and cytosol (right).   {Models were generated by 
DTM using PyMOL} 
Binding of the talin-1 FERM domain fragment F2F3 to 
negatively-charged phospholipids. 
Before studying the interaction of the talin-1 FERM domain with the 
β3 CT tethered to membrane, we investigated whether the F2F3 
subdomain, which makes the most direct contact with the β3 CT, 
differentially recognizes negatively-charged phospholipids.   We used 
surface plasmon resonance (SPR) to measure the interaction of F2F3 with 
phospholipid bilayers immobilized on a hydrophobically-modified Biacore 
L1 SPR chip (115). All measurements were made relative to a surface 
containing 100% phosphatidylcholine (PC). F2F3 binding to 20% POPS 
and 80% POPC was measured at steady state (Figure 3.4A) and 
conformed to a single-site binding model as a function of F2F3 
concentration. The dissociation constant (Kd) for F2F3 binding to 20% 
phosphatidylserine (PS)-containing bilayers was 0.92 µM (Table 3.1). In 
comparison, the Kd for bilayers containing 10% PtdIns(4,5)P2 was 0.67 
µM, suggesting that the F2F3 may have a slight preference for 
PtdIns(4,5)P2 over PS.  Nonetheless, F2F3 bound to bilayers containing 
the diphosphoinositides PtdIns(3,5)P2 and PtdIns(3,4)P2 and the 
monophosphoinositide PtdIns(5)P with affinities similar to PtdIns(4,5)P2 
and largely within the error of measurements (Figure 3.4B, Table 3.1), 
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indicating that it does not strongly differentiate between the negatively 
charged head groups.  
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Figure 3.4 Steady state binding of the talin-1 FERM domain and its 
subdomains to phospholipid bilayers. 
(A) SPR sensorgrams of F2F3 binding to a bilayer composed of 20% 
POPS and 80% POPC immobilized on a Biacore L1 SPR chip. F2F3 was 
injected in 2-fold increments up to a concentration of 10 µM. (B) Steady-
state isotherms for F2F3 binding to negatively-charged phospholipids. 
Diamonds, 10% PtdIns(4,5)P2; squares, 10% PtdIns(3,5)P2; triangles, 
10% PtdIns(3,4)P2, Xs, PtdIns(5)P, circles, 20% phosphatidylserine. (C) 
Steady-state isotherms for F0-F3 (squares), F2F3 (triangles), and F0F1 
(diamonds) binding to bilayers containing 10% PtdIns(4,5)P2.  Data from 
(B) and (C) were fit to a one-site binding model using BIAevaluation 
software. {Three independent experiments were performed.  Protein was 
purified by DTM.  SPR was performed by PN.  Data analysis was 
performed by DTM and PN.} 
 
Table 3.1 Steady-state SPR measurements of talin-1 F2F3 subdomain 
binding to phospholipids. 
Binding to the indicated phospholipids (Figure 3.4B) was fit to a one-site 
binding model using BIAevaluation.  The data represent the mean and 
standard deviations of  three independent experiments. 
 
Lipid (%) Kd (µM) Maximum Binding 
(RU) 
PS (20%) 0.92 ± 0.260 1210 ± 66 
PtdIns(4,5)P2 (10%) 0.67 ± 0.07 2490 ± 225 
PtdIns(3,4)P2 (10%) 0.42 ± 0.09 2170 ± 146 
PtdIns(3,5)P2 (10%) 0.50 ± 0.053 2330 ± 193 
PtdIns(5)P (10%)  0.37 ± 0.029 1770 ± 146 
 
The total amount of F2F3 bound to bilayers depended on the net 
negative charge of the membrane, suggesting that electrostatics play a 
substantial role in the interaction. PtdIns(4,5)P2, PtdIns(3,5)P2, and 
PtdIns(3,4)P2 each have a charge of (-4) per head group, while PtdIns(5)P 
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has a charge of (-3), and PS has a charge of (-1).  If the interaction were 
dependent of charge, the amount of protein bound to 10% PtdIns(5)P, 
would be expected to be roughly ¾ the amount bound to 10% 
diphosphoinositides.  Similarly, ½ as much talin-1 would be expected to 
bind to 20% PS as to 10% diphosphoinositides.  The maximum resonance 
units (RU) of F2F3 bound to 10% PtdIns(4,5)P2, 10% PtdIns(3,5)P2, and 
10% PtdIns(3,4)P2 were similar at 2490, 2330, and 2170 RU, respectively.  
We found that approximately ¾ the amount of F2F3 bound to 10% 
PtdIns(5)P (1770 RU) and ½ the amount bound to 20% PS (1200 RU), 
confirming that total protein bound depends on the charge of the 
membrane.  
Binding of talin-1 FERM domain and its subdomains to 
PtdIns(4,5)P2.   
Next, we compared the affinity of the complete talin-1 FERM 
domain (F0-F3) for PtdIns(4,5)P2 with that of F0F1 and F2F3.  
PtdIns(4,5)P2 was chosen as the lipid substrate for these measurements 
because F2F3 did not differentiate between various phosphoinositides. 
Phospholipid bilayers containing 10% PtdIns(4,5)P2 were immobilized on a 
Biacore L1 chip and all measurements were made relative to a surface 
containing 100% PC. We found that F0-F3 bound to 10% PtdIns(4,5)P2 
with a Kd of 980 nM, comparable to the Kd for F2F3 of 670 nM, whereas 
the Kd for F0F1 was 2.6 µM (Table 3.2).  Thus, both F0F1 and F2F3 
readily interact with PtdIns(4,5)P2, but when combined, the affinity for 
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bilayers was not enhanced. The relative stoichiometries of F0F1, F2F3, 
and F0-F3 also suggest that the subdomains do not form a cooperative 
membrane binding surface. The mass ratios for F0-F3, F2F3, and F0F1 
are 2:1.1:1.0. F0-F3 has twice the mass of F2F3 and nearly twice the 
resonance units of F0-F3 (3960 RU) bound to the sensor chip as F2F3 
(2490 RU) (Figure 3.4C, Table 3.2). Thus, F0-F3 and F2F3 have similar 
stoichiometries for the phospholipid surface. A similar amount of F0F1 
bound to the sensor chip (2290 RU) as F2F3, but with lower affinity. Thus, 
although F0F1 can interact with PtdIns(4,5)P2, the affinity and 
stoichiometry of the full FERM domain for PtdIns(4,5)P2 is similar to that of 
F2F3, indicating that F0F1 does not substantially cooperate with F2F3 in 
FERM domain binding to membranes.   
 
Table 3.2 Steady-state SPR measurements of talin FERM domain 
binding to phospholipid bilayers containing 10% PtdIns(4,5)P2. 
Binding results were fit to a one-site binding model using BIAevaluation. 
The data shown represent the mean and standard deviation of three 
independent experiments. 
 
FERM domain 
construct 
Kd (µM) Maximum Binding 
(RU) 
F0-F3 0.98 ± 0.10 3960 ± 258 
F2F3 0.67 ± 0.07 2490 ± 220 
F0F1 2.63 ± 0.84  2290 ± 258 
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Enthalpy of talin-1 FERM domain binding to PtdIns(4,5)2.  
It has been reported that the talin-1 FERM domain bind to 
negatively-charged vesicles in solution (104, 105, 111, 116, 117). To 
confirm these observations, we used isothermal titration calorimetry (ITC) 
to measure the enthalpy of F0-F3 binding to large unilamellar vesicles 
(LUVs) composed of 90% POPC and 10% PtdIns(4,5)P2. As a positive 
control, we measured binding of the pleckstrin homology (PH) domain of 
PLC-δ1 to PtdIns(4,5)P2 (30).   
Titration of 100 µM PLC-δ1 PH domain into a LUV suspension 
containing 1%, 3%, and 10% PtdIns(4,5)P2 generated binding isotherms 
with molar enthalpies of -11.7 kcal/mol, -10.2 kcal/mol, and -12.8 kcal/mol 
and dissociation constants of 2.8 µM, 2.1 µM, and 4.2 µM, respectively 
(Figure 3.5A, Table 3.3). These results are comparable to a previously 
published binding enthalpy of -11.9 kcal/mol and Kd of 1.1 µM for PLC-δ1 
PH domain binding to 1% PtdIns(4,5)P2 bilayers (30).   
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Figure 3.5 Comparison of PLC-δ1 PH domain and talin-1 FERM 
domain binding to PtdIns(4,5)P2 and Ins(1,4,5)P2. 
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(A) ITC titration of 100 µM PLC-δ1 PH domain into LUVs containing 1% 
(X), 3% (open squares), and 10% (closed squares) PtdIns(4,5)P2. The 
titrations were globally fit to a OneSite binding model using 
MicroCal/Origin. (B) ITC titration of 190 µM talin-1 FERM domain (F0-F3) 
into LUVs containing 1% (X), 3% (open squares), and 10% (closed 
squares) PtdIns(4,5)P2  No enthalpy was generated for 1% or 3% LUVs.  
Titration into 10% PtdIns(4,5)P2 was globally fit to a OneSite binding 
model using MicroCal/Origin. (C) Steady-state binding isotherms for F0-F3 
binding to 1% (triangles), 3% (squares) and 10% (diamonds) PtdIns(4,5)P2 
immobilized on a Biacore L1 SPR chip. {PLC-δ1 ITC titrations were 
performed once to demonstrate accessibility of the PtdIns(4,5)P2 
headgroup.  Talin-1 titration into 1% and 3% PtdIns(4,5)P2 were performed 
in triplicate independent experiments. Talin-1 titration into 10% 
PtdIns(4,5)P2 was performed in triplicate with the same protein sample. 
SPR data are representative of three independent experiments.  ITC 
experiments were performed by DTM.  DTM prepared protein samples for 
SPR experiments.  PN performed SPR experiments.  DTM and PN 
analyzed SPR data.} 
 
 
Table 3.3 ITC measurements of talin-1 FERM domain and PLC-δ1 
binding to  PtdIns(4,5)P2  and Ins(1,4,5)P3. 
Measurements were performed at 20ºC in 25 mM MOPS pH 6.8 with 100 
mM NaCl.  Background heats of dilution were subtracted. Titrations were 
fit to OneSite binding isotherms using MicroCal/Origin and errors are 
reported as fitting errors.  There was no net enthalpy for titration of F0-F3 
into 1% and 3% PtdIns(4,5)P2 and 2 mM Ins(1,4,5)P3.  {PLC-δ1 ITC 
experiments were performed once to demonstrate accessibility of 
PtdIns(4,5)P2 on the bilayer surface – errors represent fitting errors.  Talin-
1 titration into 1% and 3% PtdIns(4,5)P2 were performed in triplicate 
independent experiments. Talin-1 titration into 10% PtdIns(4,5)P2 was 
performed in triplicate with the same protein sample.  Talin-1 errors are 
standard deviations.  } 
 
 Ka (x106 M-1)   Kd (µM) ∆H (kcal/mol) ∆S (cal/mol/K) n 
F0-F3 + 1% 
PtdIns(4,5)P2 
-------- -------- -------- -------- -------- 
F0-F3 + 3% 
PtdIns(4,5)P2 
-------- -------- -------- -------- -------- 
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F0-F3 + 10% 
PtdIns(4,5)P2 
1.3 ± 0.6 0.781  -3.3 ± 0.4 -17.0 0.33 ± 0.03 
F0-F3 + 2 
mM 
Ins(1,4,5)P3 
-------- -------- -------- -------- -------- 
PLC-δ1 + 1% 
PtdIns(4,5)P2 
0.36 ± 0.08 
 
2.82 
  
-11.7 ± 1.0 
  
-14.0 
  
1.13 ± 0.07 
PLC-δ1 + 3% 
PtdIns(4,5)P2 
0.47 ± 0.03 2.11 -10.2 ± 0.2 -8.37 0.97 ± 0.01 
PLC-δ1 +10% 
PtdIns(4,5)P2 
0.24 ± .02 4.20 -12.8 ± 0.7 -18.3 0.75 ± 0.03 
PLC-δ1 + 2 
mM 
Ins(1,4,5)P3 
1.4 ± 0.2 
  
0.72 
  
-17.5 ± 0.7 
  
-30.5 
  
0.80 ± 0.02 
 
 
Next we titrated 190 µM F0-F3 into a suspension of LUVs 
composed of 90% POPC and 10% PtdIns(4,5)P2. After subtracting the 
heat of dilution, F0-F3 binding was slightly exothermic (≈ -3 kcal/mol) with 
a stoichiometry of ≈ 1 F0-F3 to 3 PtdIns(4,5)P2 phospholipids (Figure 
3.5B). Titration of higher F0-F3 concentrations resulted in precipitation of 
the mixture in the calorimetry cell – confirming the interaction of F0-F3 
with membranes, but precluding thermodynamic analysis. Surprisingly, 
similar experiments using LUVs containing 1% and 3% PtdIns(4,5)P2 did 
not generate measurable enthalpy (Figure 3.5B).  Therefore, to confirm 
that F0-F3 actually binds to bilayers containing 1% and 3% PtdIns(4,5)P2, 
we measured the interaction by SPR and found that it bound with high 
affinity (Figure 3.5C, Table 3.4).  Furthermore, the amount of F0-F3 bound 
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to the chip scaled with the amount of PtdIns(4,5)P2 on the surface.  The 
Rmax for 10% PtdIns(4,5)P2  was approximately 10 fold that for 1% 
PtdIns(4,5)P2.  The Rmax ratio of 10% to 3% PtdIns(4,5)P2 was 4.4, which 
was greater than the expected 3.3.  All other SPR measurements with 
F0F1, F2F3, and F0-F3 have Rmax values that scale appropriately with 
phospholipid charge and protein mass (Tables 3.1 and 3.2), therefore it is 
unclear why the 3% PtdIns(4,5)P2  surface would deviate.  The experiment 
was repeated several times with different protein preparations and lipid 
stocks.   
 
Table 3.4 Steady-state SPR measurements of talin F0-F3 domain 
binding to phospholipid bilayers containing 10%, 3%, and 1% 
PtdIns(4,5)P2. 
Binding results were fit to a one-site binding model using BIAevaluation. 
The data shown represent the mean and standard deviation of three 
independent experiments. 
 
Negatively Charged 
Phospholipid 
Kd (µM) Maximum Binding 
(RU) 
10% PtdIns(4,5)P2 0.98 ± 0.10 3960 ± 258 
3% PtdIns(4,5)P2 0.70 ± 0.21 901 ± 57 
1% PtdIns(4,5)P2 0.65  ± 0.28 427 ± 24 
 
Lastly, we attempted to measure the interaction of F0-F3 with the 
inositol headgroup of PtdIns(4,5)P2, Ins(1,4,5)P3, free in solution (Figure 
3.6). Two mM Ins(1,4,5)P3 was titrated into a 150 µM F0-F3 solution, but 
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no binding enthalpy was generated. By contrast, titration of 120 µM 
Ins(1,4,5)P3 into a 6 µM solution of the PLC-δ1 PH domain generated an 
exothermic binding curve with thermodynamic parameters comparable to 
previously published results (Table 3.3) (30).  
 
Figure 3.6 Titration of Ins(1,4,5)P3 into talin-1 F0-F3 does not 
generate significant enthalpy. 
ITC titrations of 2 mM Ins(1,4,5)P3 into 150 µM F0-F3 (filled squares) and 
120 mM Ins(1,4,5)P3 into 6.0 mM PLC-δ1 (open squares).  The titration 
into PLC-δ1 could be fit to a OneSite model (MicroCal/Origin). All samples 
were prepared in buffer matched 25 mM MOPS 100 mM NaCl, pH 6.8.  
Background heats of dilution were subtracted.   {Titration of Ins(1,4,5)P3 
into F0-F3 is representative of two independent experiments.  Titration of 
Ins(1,4,5)P3 into PLC-δ1 was performed once to demonstrate activity of 
Ins(1,4,5)P3. Experiments performed by DTM.} 
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Talin-1 FERM domain binding to the β3 CT immobilized on 
negatively charged carboxymethylated dextran.  
Previous measurements of talin-1 FERM domain binding to the β3 
CT used a β3 construct beginning at Lys716 and included a linker for 
attaching the construct to an SPR chip (114). Our β3 CT construct, 
designed to mimic the β3 CT as it exits the membrane, was attached via 
Cys719 to a CM-5 SPR sensor chip functionalized with N-[ε-
maleimidocaproic acid]-hydrazide to generate thiol-reactive groups (Figure 
3.2). F0-F3 was then flowed over the chip at concentrations up to 1.0 µM. 
The resulting sensorgrams (Figure 3.7A) could be fit to two binding events 
with dissociation constants of 155 nM and 3.5 µM. The biphasic behavior 
could have resulted from heterogeneity of β3 on the chip surface or 
heterogeneity of the interaction between F0-F3 and the 
carboxymethylated dextran (118). Regardless, the interaction between the 
talin-1 FERM domain and the β3 CT may be sensitive to such 
heterogeneity since we hypothesize that the FERM domain binds to the β3 
CT and the inner membrane surface simultaneously.  We chose not to 
pursue experiments with carboxy-dextran-immobilized integrin further, as 
membrane immobilized β3 is more biologically relevant and immobilization 
of small peptides on dextran matrices can result in heterogenous 
interaction surfaces.   
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Figure 3.7. Talin-1 FERM domain binding to the β3 CT immobilized on 
negatively-charged surfaces or free in solution. 
(A) The β3 CT (600 RU) was immobilized on a carboxy-methylated 
dextran SPR chip and F0-F3 to maximum concentration of 1 µM was 
flowed over the chip.  (B) FP of F0-F3 titrated into 20 nM BODIPY-TMR 
β3. FP was measured at 575 nm after excitation at 530 nm (squares). F0-
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F3 was also titrated into a 20 nM FITC-labeled PIP5KI-γ (black circles). FP 
was measured at 528 nm after excitation at 485 nm. (C)  ITC of 140 µM β3 
CT titrated into buffer-matched 10.5 µM F0-F3 revealed no significant 
enthalpy above the heat of dilution.  ITC samples were in 25 mM MOPS 
100 mM NaCl, pH 6.8.  {SPR data are representative of two independent 
experiments.  Fluorescence polarization experiments were performed in 
triplicate using the same protein sample.  ITC data are representative of 
three independent experiments – no binding enthalpy was generated in all 
three experiments.  SPR was performed and analyzed by PN using 
protein prepared by DTM.  FP performed by DTM.  PIP5K1γ peptide was 
prepared by HJ.  Integrin peptide was prepared by DTM.  ITC performed 
by DTM.} 
 
Binding of the talin-1 FERM domain to the β3 CT domain 
tethered to negatively-charged bilayer.  
To address whether the talin-1 FERM domain binds the β3 CT and 
a negatively-charged surface in a concerted fashion, we first used 
fluorescence polarization (FP) and ITC to measure the affinity of talin-1 
FERM domain for the β3 CT when both are free in solution.   
For FP, the β3 CT was labeled with maleimide-functionalized 
BODIPY-TMR at Cys719.  When F0-F3, at concentrations up to 100 µM, 
was titrated into a 20 nM solution of labeled β3 CT, the FP increased from 
0.1 to 0.16. (Figure 3.7B).  These results were fit to a binding isotherm 
with a Kd of approximately 600 µM.  Since the interaction between talin-1 
and β3 CT was not saturated at the concentrations used, the exact 
dissociation constant could not be calculated, however other laboratories 
have reported values on the order of several hundred micromolar (62, 
112), which is in line with our results.  As a positive control for talin-1 
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activity, we titrated F0-F3 into a 20 nM solution of a fluorescein 
isothiocyanate (FITC)-labeled peptide corresponding to the C-terminus of 
PIP5KIγ (Figure 3.7B). The resulting change in FP was fit to an isotherm 
with a Kd of 160 nM ± 50 nM, consistent with reported affinities of 170 nM 
to 1.4 µM for other PIP5KIγ constructs with slightly different sequences 
(119, 120).   
We also used ITC to confirm that the β3 CT and F0-F3 does not 
interact strongly in solution. There was no significant enthalpy above 
background heats of dilution when F0-F3, up to a final concentration of ≈ 
30 µM protein, was titrated into 10 µM peptide (Figure 3.7C). This 
contrasts with a recent report in which talin-2 and the β1D cytoplasmic 
domain interacted with a Kd of ≈ 20 µM and a molar enthalpy of ≈ -17 
kcal/mol (112).  This difference is associated with several subtle but 
significant differences between the β1D CT and β3 CT sequences.  Our 
result can be interpreted either as a lack of interaction between talin-1 and 
the β3 CT at the concentrations used or a lack of significant enthalpy at 
the concentrations used.  Given that the structural similarity of the talin-2 / 
β1D interaction (∆H ≈ -17 kcal/mol), we would expect the β3 interaction to 
have measurable enthalpy at the concentrations used in this experiment.  
Furthermore, the lack of observed enthalpy corroborates our FP data and 
previously published NMR experiments (62, 112).   
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Figure 3.8. Talin-1 FERM domain binding to the β3 CT conjugated to 
phospholipid bilayers containing 1% PtdIns(4,5)P2. 
The β3 CT at a final concentration of 5 µM was immobilized onto the 
surface of LUVs containing 1% PtdIns(4,5)P2 (20 µM)/ 2% maleimide-PE 
(40 µM) / 97% POPC (2 mM total lipid).  Buffer matched talin-1 FERM 
domain (F0-F3, 150 µM) was titrated at 20°C into the suspension of 
immobilized β3. Background heats of dilution were subtracted.  The 
titration was globally fit to a OneSite binding model using MicroCal/Origin.  
All ITC experiments were performed in 25 mM MOPS buffer 100 mM 
NaCl, pH 6.8.  Thermodynamic parameters are summarized in Table 3.5.  
{Data represent three independent experiments.  Experiments performed 
by DTM.} 
 
Because the interaction between the talin-1 FERM domain and 
PtdIns(4,5)P2 occurs with very low enthalpy, we were able to use ITC to 
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measure talin-1 FERM domain binding to the β3 CT in the presence of 
PtdIns(4,5)P2. Accordingly, we immobilized the β3 CT on phospholipid 
bilayers by reacting a β3 CT construct containing Cys at residue 719 with 
maleimide-functionalized phosphatidylethanolamine on the surface of 
LUVs composed of POPC and 1% PtdIns(4,5)P2, 20% PS, or 20% PS + 
1% PtdIns(4,5)P2 (1). Titration of F0-F3 into a suspension of LUVs 
containing 1% PtdIns(4,5)P2 in the absence of immobilized β3 CT (Figure 
3.5B) or into buffer containing the free β3 CT (Figure 3.4C) generated little 
or no enthalpy.  By contrast, titration of 150 µM F0-F3 into a LUV 
suspension containing 5 µM β3 CT immobilized on 1% PtdIns(4,5)P2 was 
exothermic (Figure 3.8).  The titration was globally fit to a one-site binding 
isotherm, revealing a Kd of 860 nM and a molar enthalpy of -25.0 kcal/mol 
(Table 3.5).  When the experiments were repeated with the β3 CT 
immobilized on bilayers containing 20% PS or 20% PS with 1% 
PtdIns(4,5)P2 similar results were obtained (Figure 3.9A/B; Table 3.5). 
Thus, these experiments demonstrate that immobilizing the β3 CT on 
phospholipid bilayers increases its affinity for the talin-1 FERM domain by 
at least three orders of magnitude compared to the β3 CT free in solution, 
increasing its affinity from that of a very weak to a high-affinity interaction.    
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Figure 3.9 FERM domain binding to the β3 CT conjugated to 
negatively-charged phospholipid bilayers. 
As in Figure 3.5k, the talin-1 FERM domain (F0-F3, 150 µM) was titrated 
at 20°C into a buffer-matched suspension of LUVs composed of (A) 20% 
PS or (B) 20% PS + 1% PtdIns(4,5)P2 to which 5 µM β3 CT had been 
conjugated via a maleimide-functionalized lipid head group (Methods).  
The titrations were globally fit to a OneSite binding model using 
MicroCal/Origin. Thermodynamic parameters are summarized in Table 
3.5.  {Data are representative of triplicate experiments performed with the 
same protein sample.  Experiments were performed by DTM.} 
 
 
 
Table 3.5 ITC measurements of talin-1 FERM domain binding to the 
β3 CT attached to large unilamellar phospholipid vesicles (LUVs). 
The talin-1 FERM domain was titrated into LUV suspensions containing 5 
µM immobilized β3 CT (Figures 3.8 and 3.9). All experiments were 
performed at 20ºC in 25 mM MOPS pH 6.8 with 100 mM NaCl and 
background heats of dilution were subtracted.  Titrations were fit to one-
site binding isotherms.  {Titration into β3 on 1% PtdIns(4,5)P2 was 
performed as three independent experiments and errors are reported as 
standard deviations.  Titration into β3 on 20% PS and 20% PS with 1% 
PtdIns(4,5)P2 was performed once with each sample and the error is 
reported as the fitting error. All experiments were performed by DTM.} 
79 
 
 
 Ka (x106 
M-1) 
Kd 
(µM) 
∆H(kcal/mol) ∆S(cal/mol/K) n 
β3-
1%PtdIns(4,5)P2 
1.19 ± 
0.21 
0.86 -25.0 ± 1.5 -55.8 0.80 ± 
0.04 
β3-20% PS  0.29 ± 
0.02 
3.4  -32.3 ± 0.9 -83.3 0.8 
(held) 
β3-20%PS + 
1%PtdIns(4,5)P2  
0.61 ± 
0.11 
1.6  -34.0 ± 2.8 -87.5 0.95 ± 
.06 
 
III.  Discussion 
Here we found that presentation of the β3 CT in the context of an 
acidic bilayer enhances its affinity for the talin-1 FERM domain up to three 
orders of magnitude, depending on the phospholipid composition of the 
bilayer. However, FERM domain binding to the β3 CT contrasts with the 
stronger interaction of the FERM domain with PIP5K1γ and with the 
interaction of the talin-2 FERM domain and the β1D CT. Small changes in 
integrin β CT sequences have been shown to significantly increase their 
affinities for talin family FERM domains (112). This suggests that the 
interaction between the talin-1 FERM domain and the β3 CT has been 
evolutionarily tuned to be intrinsically weak, allowing it to be modulated by 
changes in phospholipid composition, post-translational modifications, and 
additional protein-protein interactions.   
To understand how these protein-protein and lipid-protein 
interactions modulate affinity, it is important to consider the various 
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energetic components associated with the interaction of the talin-1 FERM 
domain and the β3 CT with lipids, as well as their interaction with each 
other. Previous studies reported the interaction of the talin-1 FERM 
domain and the β3 CT with micelles and phospholipid vesicles (1, 16, 38, 
54, 106). Here, we studied this interaction using the β3 CT tethered to 
phospholipid bilayers to understand the energetics of the overall process. 
Previously, we used this construct to study the dynamics of the β3 CT in 
the presence of bilayers by hydrogen-deuterium exchange (HDX).  
Although the construct lacks a transmembrane domain, it was designed 
computationally to attach via a residue predicted to be at the membrane 
interface and it contains all of the β3 residues necessary for interaction 
with talin-1.  While it is possible that the TM domain could affect this 
interaction, our NMR and HDX studies indicate that the TM helix is broken 
by a kink as it exits the membrane, implying that the structure of the β3 CT 
distal to the helix disruption is unlikely to depend on residues buried within 
the membrane.  Furthermore, our construct contains all of the β3 residues 
necessary for formation of the kink (Figure 2.5).   
We can consider the overall free energy for the interactions of the 
bilayer-tethered β3 CT (RTln(Kobs) = ∆Goverall) in terms of several 
components according to Eq. 1 below. It should be noted that this 
thermodynamic decomposition is path-independent and does not require 
kinetic ordering; nevertheless, all interactions here were rapid, on the 
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second to msec time scale, indicating that they might rapidly interconvert 
on a physiologically relevant time scale.  
Eq. 1:   ∆Goverall = ∆Gtalin-bilayer + ∆Gtalin-peptide + ∆Greorganization 
where:  
∆Gtalin-bilayer is the energy associated with talin-1 head interaction with lipid, 
as determined directly from the titration of the FERM domains into lipid 
bilayers; 
∆Gtalin-peptide is the energy associated with talin-1 head interaction with the 
β3 CT, as determined directly from the NMR or the fluorescent titrations 
reported above and which is sequence-specific (112) but only weakly 
favorable (Kdiss on the order of 0.2 to 0.6 mM). 
∆Greorganization is the free energy required to rearrange the conformations of 
isolated individual components and binary complexes to allow formation of 
a ternary complex.  
The electrostatic surfaces of F3, F2F3, and the full FERM domain 
(44, 104) suggest that F2F3 binds negatively-charged bilayers in a 
manner highly conducive to forming a simultaneous interaction with the β3 
CT; this finding has been supported by detailed coarse-grained molecular 
dynamics calculations (106). Thus, there is likely little reorganization 
energy associated with the interaction of these subdomains with bilayers. 
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By contrast, the β3 CT, tethered to a bilayer, is in a rapid equilibrium that 
favors a conformation in which the peptide interacts with the membrane in 
a way that masks residues important for talin-1 binding and that would 
otherwise be located 10 – 30 Å into the cytoplasm (1).  A second 
minor conformation is more exposed to the aqueous surroundings, 
presumably allowing rapid kinetic access to the FERM domain.  
Hydrogen-deuterium exchange showed that the equilibrium favors the 
membrane-associated state by 100 to 1000-fold relative to the exposed 
state (Chapter 2), decreasing the overall affinity for binding cytosolic 
proteins by an equivalent amount. Thus, we expect that ∆Grearrange would 
be dominated by the rearrangement of the β3 CT within the bilayer.   
Consideration of Eq. 1 shows that cytosolic protein binding to the 
β3 CT in a proper context depends on an energetic balance, which, in this 
case, includes a highly favorable interaction between talin-1 and the 
membrane. A modestly favorable free energy of interaction of the β3 CT 
with the talin-1 head is balanced by a modestly unfavorable free energy of 
rearrangement of the β3 CT within the bilayer.  In net, the observed affinity 
for formation of the ternary complex remains similar to that for the binary 
interaction of the talin-1 head with acidic bilayers. Likewise, in the absence 
of integrin, the binary complex between the FERM domain and the 
membrane appears to energetically favor the F2F3 subunit, as F0F1 does 
not affect the overall affinity or stoichiometry of the interaction. This 
suggests that F0F1 might not interact favorably with the bilayer once it is 
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tethered in place by the more stable F2F3 interaction. Alternatively, F0F1 
might interact extensively when the FERM domain binds, but only after an 
energetically uphill conformational change that attenuates the overall 
affinity gain associated with F0F1-bilayer interaction.  It is likely not 
accidental that the binary and ternary complexes are not optimized for 
cooperativity.  Rather they appear to be tuned to be readily regulated by 
changes in the lipid environment and by post-translational modifications.  
In summary, our studies reveal the rich interplay between structure, 
dynamics, kinetics, and thermodynamics that govern formation of the 
ternary complex between the β3 CT, phospholipid bilayers, and talin-1 
FERM domain. This energetic dissection provides the basis for 
understanding how posttranslational modifications and changes in lipid 
composition might affect such processes. The situation becomes more 
complex as interactions with additional domains in integrin and talin, as 
well as other antagonistic or synergistic cytoplasmic proteins, are 
considered. Nevertheless, the present study illustrates the importance of 
considering the role of conformational changes, structural 
rearrangements, and conformational entropy in these processes, and 
provides a general approach to energetic decomposition that can form the 
basis for understanding regulation of even more complex systems. 
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IV.  Methods 
Design of recombinant talin-1, β3 CT and PIP5K1γ constructs. Talin-1, 
β3 CT, and PIP5K1γ constructs were cloned between the NdeI and XhoI 
restriction sites of the vector pet28a and contained an N-terminal 6xHis 
tag for purification, followed by a thrombin cleavage site for affinity tag 
removal. The talin-1 constructs (Figure 3.2, A-C) consisted of the entire 
talin-1 FERM domain (F0-F3), extending from its N-terminus through 
residue Ser425, the F0F1 subdomains extending from the N-terminus 
through residue Asp201, and the F2F3 subdomains spanning residues 
Ser206 through Ser425.    
The β3 CT construct (Figure 3.2D), encompassing residues Thr720 
through the C-terminus at Thr762, was previously described (1).  For the 
current experiments, residue Ile719 was replaced with Cys to enable the 
construct to be immobilized on the surface of bilayers or to be labeled via 
maleimide chemistry. A peptide corresponding to residues 646-654 of 
PIP5K1γ was also labeled with fluorescein isothiocyanate (FITC) (Figure 
3.2E).  
Talin-1 and PIP5K1γ were introduced into BL21-DE3 cells 
(Novagen) and expressed for 20 h at 20°C in the presence of 0.5 mM 
IPTG.  Cells were then lysed by sonication on ice in 20 mM imidazole 
buffer, pH 7.0, containing 500 mM NaCl, 1 mM EDTA, and a protease 
inhibitor cocktail (Sigma-Aldrich).  After the lysates were cleared by 
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centrifugation, the supernatants were loaded onto HiTrap Ni-NTA columns 
(GE Healthcare) and peptides were eluted using an imidazole gradient. 
Imidazole was dialyzed away overnight into 50 mM Tris buffer, pH 7.5 
containing 100 mM NaCl and the 6xHis tag was removed using thrombin.  
The constructs were then purified by SP ion exchange chromatography 
(GE Healthcare) and finally size exclusion chromatography with a 
Superdex 75 preparative column (GE Healthcare).    
Preparation of large unilamellar vesicles (LUVs).   LUVs were 
generated by evaporating a mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC, Avanti Polar Lipids) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-L serine (POPS, Avanti Polar Lipids) dissolved were 
dissolved in chloroform under nitrogen; excess chloroform was removed 
under high vacuum overnight.  Phosphoinositides (Cell Signaling) were 
dissolved in CHCl3/MeOH/0.1% HCl, mixed with POPC, and dried under 
nitrogen.  Evaporated lipids were then re-suspended in buffer, vortexed 
vigorously for 5 minutes, subjected to 3 x freeze- thaw cycles, and 
extruded 20 to 30 times using 100 nm diameter filters (Avanti Polar 
Lipids).   
Preparation of membrane tethered β3. Lyophilized β3 CT was re-
dissolved in bilayer conjugation buffer (25mM sodium phosphate or 
MOPS, 100 mM NaCl, pH 6.8) at a concentration of 50 µM.   Large 
unilamelar vesicles (LUVs) were generated by evaporating a mixture of 
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1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-
maleimidomethyl)cyclohexane-carboxamide] (16:0 PE MCC, Avanti Polar 
Lipids), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti 
Polar Lipids), and the appropriate negatively charged lipid under nitrogen.  
The lipids re-suspended in the bilayer conjugation buffer.  LUVs were 
prepared by extruding 20 times through a 0.1 µm filter (Avanti Polar 
Lipids).  β3 CT was reacted with 4 fold molar excess 16:0 10 PE MCC.  
The conjugation reaction was performed at pH 6.8 to minimize lysine 
amine-maleimide side reactions which are strongly disfavored at below pH 
7.  After reacting the β3 CT with the surface of the membrane for three 
hours, the bilayers were quenched with excess β-mercaptoethanol and 
dialyzed overnight.  The final lipid concentration was calibrated using a 
POPC standard to calculate the amount of POPC in the β3-conjugated 
bilayer.   
Isothermal titration calorimetry (ITC).  ITC experiments were performed 
on a  MicroCa ITC200 (MicroCal/GE). Samples were prepared in 
degassed 25 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffer, 
pH 6.8, containing 100 mM NaCl.  Samples were loaded into cells after 
vigorous washing with buffer and syringes were loaded with 50 µL of 
titrant.  Each experiment consisted of 20 x 2.0 µL injections spaced at 
intervals of 2-5 minutes.  A 0.2 µL injection preceded all experiments and 
was not included in fitting.  Fitting was performed using the Origin software 
suite (MicroCal/Origin Systems) as single binding events. Heats of dilution 
87 
 
were calculated by titration into the prepared diazylate and subtracted 
prior to fitting. 
Surface plasmon resonance (SPR).  All SPR experiments were 
performed on a Biacore 3000 (GE Healthcare).  Each injection was done 
in triplicate. Kinetic experiments were performed in degassed 10 mM (4-
(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer, pH 7.2, 
containing 100 mM NaCl. The CM5 chip was activated using an amine 
coupling kit (GE Healthcare). N-(2-Aminoethyl)maleimide (pH 7.0) was 
then injected and non-reacted activated groups were capped with 1 M 
ethanolamine (pH 7.0). The β3 CT was immobilized onto the CM5 chip via 
maleimide crosslinking to ≈ 600 RU.  Background maleimide was 
quenched with 2-mercaptoethanol. Talin-1 FERM domain constructs 
were injected at 50 µL/min with a 2 min injection time and 400 sec 
dissociation time. Binding data were fit to a double exponential using the 
BIAvaluation software.   
For steady-state experiments, 100 nm LUVs were loaded onto an L1 chip. 
Talin-1 FERM domain constructs were injected for 10 min with a 120 sec 
dissociation time and a 10 µL/min flow rate.  Between injections, new lipid 
surfaces were generated when full dissociation was not observed. Steady 
state construct binding was compared to a reference channel containing 
100% POPC. Binding was fit to a single component isotherm equation: Req 
= (KA * [analyte]*RUmax)/ (KA *[analyte]*n+1)+background.   
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Fluorescence Polarization (FP). FP experiments were performed as 
previously described (121). Briefly, FP was conducted in an ATF105 
spectrofluorometer (Aviv Instrument, Inc) using a 0.3 cm path length 
cuvette. Spectra were measured using 1.0 nm slit widths at 25˚C.  The β3 
CT was labeled with maleimide-BODIPY-TMR at a cysteine introduced at 
residue 719. Talin-1 F0-F3 was titrated into 20 nM β3 BODIPY-TMR and 
FP was measured at 575 nm after excitation at 530 nm. When F0-F3 was 
titrated into 20 nM FITC-labeled PIP5KI-γ, a dissociation constant and 
baseline parameters were derived from the fluorescence anisotropy 
signal/concentration isotherm using previously described methods (121). 
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Chapter 4 Transmembrane communication: general 
principles and lessons integrins and other 
receptors.   
 
I.  Introduction 
 In this review we explore how the binding of ligands to proteins 
induces functional conformational changes. Ligand induced 
conformational changes are fundamental to every aspect of protein 
function; for example, when an enzyme binds its substrate the act of 
binding induces changes in the protein’s structure and dynamics to 
improve catalysis (122-124). Thus, it is often difficult to separate binding 
from catalysis. Similarly, binding of an allosteric ligand can lead to the 
propagation of conformational changes over long distances. We focus 
primarily on the generation and transmission of conformational changes in 
membrane proteins; we first introduce the types and limits of coupled, 
ligand induced conformational changes. Next we examine in quantitative 
terms the effects of different coupling mechanisms. 
 We then explore how ligand-binding affects the structures and 
functions of various membrane protein including bacterial histidine kinases 
and integrins, exploring the mechanisms by which multiple proteins, small 
molecules, metal ions, phospholipids, and post-translational modifications 
influence their activation and signaling.  Finally, we demonstrate how 
interdomain coupling can generate diverse integrin signals.   
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II.  Results 
The coupling of ligand binding and environmental effects to 
conformational changes 
Ligand binding generally leads to changes in both structure and 
dynamics, with increases and decreases in dynamics often occurring at 
different sites of the same protein(125). The effect of ligand binding on 
protein activity can be viewed in light of classical thermodynamic concepts 
of allostery, induced fit or conformational selection, and cooperativity(122-
127). For simplicity, we consider a two-state transition between an active 
and resting state. The experimentally observed change in activity depends 
on several factors including: 1) the free energy difference or “energy gap” 
between the active and resting states, which determines the fraction of the 
protein in the activated state in the absence of the ligand, 2) the affinity of 
the protein for the ligand and their concentrations, and 3) the ability of the 
ligand to induce a transition when fully bound. Less than complete 
activation occurs, even when the ligand is fully bound, if it binds to both 
the activated and the resting conformations; in this case, the extent of 
activation relates to the relative affinity of the ligand for the activated 
versus resting state. These concepts of coupled equilibria are well studied 
and understood. Relating these to such phenomena as partial activation, 
potentiation, and synergistic ligands, is a simple matter of algebraic book-
keeping, as shown in later sections. 
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In the next section, we explore in more quantitative terms how 
these simple binding phenomena lead to a variety of activation curves, 
when there are multiple ligands capable of activating the protein of 
interest. In this case, distinct ligand-binding sites at different locations can 
“couple” to give a variety of outcomes; the binding of one can alter the 
affinity of the other for the protein, and they can have additive or non-
additive effects on the degree of maximal activation upon ligand 
saturation. 
The coupling of binding and functional transitions refers to the 
phenomenon by which the binding of a ligand to one site influences the 
structure, dynamics, and binding affinity at a second site, which relates to 
the protein’s energy gap and the ratio of affinities of the regulatory ligand 
for the activated versus the resting states. Given these simple 
requirements, it is not surprising that coupling can be achieved in different 
ways. One special case is when the binding of a ligand induces a change 
in association state. When no change in association is observed, it is often 
implicitly assumed that signaling occurs via “hard connections” in which 
helices shift, tilt or change register, mechanically driving a conformational 
change that propagates across a bilayer. A second model involves 
communication between subunits, which can involve large-scale or subtle 
changes in interactions between domains or between domains connected 
by flexible linkers. These different modes of communication can lead to 
different outcomes, when one measures the effects of mutations at 
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positions between the binding sites. For example, if a domain shifts as a 
rigid body, the search for a “pathway” from one location to the other might 
give rise to different results than if the transition of structural and dynamic 
information occurs by correlated motions of sidechains that propagate in a 
two-state manner between the two sites. 
Finally, both the magnitude as well as the sign of the energy gap of 
a transmembrane (TM) protein depends on the membrane environment. 
Any shift in structure that changes the exposure of specific residues or the 
width (cross-sectional surface area) of a protein at a given position in the 
membrane will make the energy gap sensitive to the physical properties of 
the bilayer. Hence, mechanosensitive channels switch on in response to 
changes in bilayer tension(128). Potassium channels respond to the 
transmembrane electrical potential, and the location and coupling of 
cytoplasmic loops and helices changes in response to the fraction of IP 
lipids, sphingomyelin, and cholesterol in the bilayer(129-132). Indeed, the 
hydrophobic length of transmembrane helices is reflected in the width of 
the bilayers in the organelles to which they localize. Additionally, once 
located in a given membrane, there is tight coupling between the lipid 
environment and the conformation of the protein, as it, for example, 
partitions into cholesterol/sphingomyelin rich phases(133, 134). 
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Simple models for energetic coupling 
Energy gap It is convenient to think of functional proteins as having at 
least two thermodynamic states – a resting state and an active state. The 
free-energy gap between these, inactiveactivegap GGG −=∆  determines the 
equilibrium fraction of active protein as ( )[ ]RTGf gapactive ∆+= exp1
1
. Since 
the largest possible fraction of the protein in the active state is 1, this also 
determines the maximal attainable degree of activation due to binding of 
any ligand or perturbation, via ( )RTGA gap∆+= exp1 . For example, if gapG∆  
is 0.41 kcal/mol, then at room temperature the fraction activation is 31 .  
Therefore, even the best activating agent can only result in a 3-fold 
increase in activity. However, if gapG∆  is 6.82 kcal/mol, the maximal 
degree of activation is 105. 
 A ligand causes activation when it binds with higher affinity to the 
active relative to the inactive state (see Figure 4.1A/B). If AK  and IK  are 
the dissociation constants for the ligand binding to the active and inactive 
states, respectively, then the ligand is activating if IA KK < . Moreover, the 
fraction AI KK  determines the activating potential of the ligand. When the 
system is saturated with ligand, the free energy difference between active 
and inactive states becomes: ( ) gapAIeffgap GKKRTG ∆+−=∆ ln . For an ideal 
activating ligand, IK  approaches infinity, such that ligand saturation leads 
to complete activation, and the degree of activation is only limited by the 
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intrinsic gapG∆ . If a ligand binds to both states, the maximum degree of 
activation is ( ) ( ) RTGAI
RTG
AI gap
gap
eKK
eKKA ∆−
∆−
⋅+
+
⋅=
1
1
, and is limited by both the 
intrinsic gapG∆  and the ratio of equilibrium binding constants AI KK  (see 
Figure 4.1B). For a given protein (and a fixed gapG∆ ), this ratio of 
equilibrium binding constants could differ for different ligands, leading to 
varying degrees of activation upon ligand saturation. The specifics of a 
biological process determine how large gapG∆  needs to be and how it is 
modulated by binding. Large gapG∆  and AI KK  lead to a high degree of 
maximal activation (Figure 4.1B). A large gapG∆  is also useful in situations 
with multiple effectors that act in a combinatorial manner. 
 
 
Environment gapG∆  can be modulated by environmental variables, such as 
the membrane composition. While it may be possible to treat membrane 
effects as ensembles of binding sites, we treat them as environmental 
factors modulating gapG∆  in the simplest case.  
 
Coupling Once the receptor ectodomain shifts into its active state, this 
information is transmitted onto the functional cytoplasmic end of the 
molecule. This is sometimes referred to as allostery and is equivalent to 
stating that one end of the molecule is thermodynamically coupled to the 
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other. This coupling depends on the specifics of the molecule’s structure 
and dynamics, but can be thought of as arising from differences in inter-
domain interaction free energies when in different states. This inter-
domain coupling or allostery can therefore be captured with a 
thermodynamic coupling free energy parameter, 
cG∆∆ , which determines 
the extent to which the different domains experience each other’s states.  
 
Simple Model 1. A two-state extracellular receptor domain, with an energy 
gap RgapG∆ , receives input from a signaling ligand, which binds 
preferentially to the active state of the receptor (Figure 4.1C). The receptor 
domain is thermodynamically coupled, via the coupling parameter RcG∆∆ , 
to the cytoplasmic domain, which carries out the function of the system in 
its active state. The intrinsic activity of the cytoplasmic domain is 
controlled by its own energy gap, CgapG∆ . Figure 4.1D shows how the 
activity profile of this system (e.g. level of activation as a function of ligand 
concentration) depends on CgapG∆  and RcG∆∆ . Because the function of the 
overall system is based on the activity of the cytoplasmic domain, high 
values of its gap lead to low levels of background activity, thus more 
switch-like behavior (compare profiles at low and high CgapG∆  in Figure 
4.1C). However, because the two domains are coupled, the energy gap of 
the receptor domain also influences the level of activation. In fact, the 
96 
 
energy gaps of the two domains can be thought of as jointly modulating 
the overall effective energy gap of the system, as shown in Figure 4.1C. 
 
Figure 4.1 Simple linked-equilibria models.   
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(A)  A thermodynamic cycle illustrating the coupling between activation of 
a two-state protein and ligand binding. (B) Activation profiles of a two-state 
protein as a function of an agonist ligand concentration. Ratio of 
dissociation constants for the inactive and active states, AI KK , and the 
intrinsic energy gap, gapG∆ , determine maximal attainable activation. (C) A 
diagram of a simple signal-transduction molecule. Two domains, a 
receptor domain and a cytoplasmic functional domain, each with two 
states, are thermodynamically coupled, with the receptor modulated by an 
activating ligand. All eight states of the system are explicitly shown and 
the indicated equilibrium free energy differences correspond to the 
direction of the arrow with which they are shown. Free energy differences 
between ligand-bound states (back side of the cube) are omitted for 
simplicity, but follow simply from thermodynamic cycles. L indicates the 
concentration of the cytoplasmic ligand. (D) Activation profiles of the 
system in (C) as a function of the energy gap of the cytoplasmic domain, 
C
gapG∆ , and coupling of the receptor to the cytoplasmic domain, RcG∆ . AK  
and IK  are set to 10 nM and 20 µM, respectively, and the energy gap of 
the receptor domain, RgapG∆ , is set to 3.0 kcal/mol. The effective energy 
gap for this system can be shown to be 
( ) ( ) ( )
( ) ( ) ( )
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11ln . Thus, if 
R
cG∆∆  is zero (i.e. there is no coupling between the domain), the overall 
gap is just CgapG∆ , but as long as RcG∆∆  is negative (i.e. activation of the 
receptor promotes the active state of the functional domain), higher values 
of RgapG∆  contribute to a higher overall energy gap. Similarly, tighter 
coupling (lower R
cG∆∆ ), leads to a higher overall gap larger degree of 
maximal activation. 
 
Simple Model 2 If the TM domain has active and inactive states, the 
system has 16 total states (Figure 4.2A), and the activation profile 
depends on the energy gap of the TM domain and its coupling to the 
cytoplasmic domain. Whereas larger energy gaps of the cytoplasmic 
domain always lead to larger overall energy gaps of the system (i.e. larger 
degree of maximal activation), this is not necessarily the case for the 
energy gap of the TM domain (see Figure 4.2B), and the effect of 
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increasing TMgapG∆  can go in either direction, depending on the other 
parameters. Intuitively, this is because unlike CgapG∆ , TMgapG∆  does not 
directly modulate the activity of the functional cytoplasmic domain, but 
rather does so through thermodynamic coupling. Increasing TMgapG∆  leads to 
lowering of the absolute active fraction of the cytoplasmic domain, by 
virtue of the two domains being coupled. This serves to silence 
background activity in the resting state, while in the presence of activating 
ligand it limits the maximal fraction of active protein. The overall 
consequence depends on which of these two effects dominates.  Because 
the TM domain lowers activity at resting state, it may provide higher levels 
of activation compared to a system without a two-state TM domain (Figure 
4.2B).  This illustrates the advantage of having multiple loosely-coupled 
domains – it allows for strong switching behavior without resorting to large 
energy barriers between active and inactive states. Intermediate domains 
also provide additional opportunities for modulation of the signal. 
Additional environmental conditions, such as the state of the membrane or 
the presence of specific ligands, can be integrated into the final output of 
the signaling system.  
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Figure 4.2 A more complex model of a signaling molecule. 
 (A) In addition to the receptor and functional cytoplasmic domains as in 
Figure 4.1, here the TM domain is explicitly modeled as having two states. 
The intrinsic fraction of TM domain in the active state is defined by TMgapG∆ , 
and it is coupled to the cytoplasmic domain via TM
cG∆ . The sixteen states 
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of the system along with the corresponding free energies are shown in the 
table on the right. (B) The dependence of activation profiles on TMgapG∆  and 
TM
cG∆ . AK  and IK  are set to 10 nM and 20 µM, respectively, and values 
of other parameters are shown. The line with circles demonstrates the 
case where no two-state TM domain is present, and the receptor domain 
couples directly to the cytoplasmic domain with the same RgapG∆  as in other 
models. 
 
Simple Model 3  Extracellular and intracellular signals can be integrated 
by the same receptor. The VirA/VirG two-component system from 
Agrobacterium tumefaciens integrates multiple inputs with both its 
extracellular and cytoplasmic domains, including plant phenolic signaling 
molecules, monosaccharides, and pH(135). This can be modeled with the 
addition of a two-state cytoplasmic linker domain (Figure 4.3A). An 
intracellular ligand, such as a phenolic molecule, binds stronger to the 
activated state than the inactive one (ligand C in Figure 4.3A), whereas a 
different ligand, such as a sugar, modulates the states of the receptor 
domain (ligand L in Figure 4.3A). Both the maximal activation as well as 
the concentration of half-maximal activity (IC50) change for one ligand in 
response to different concentrations of the other (Figure 4.3B). Such 
cumulative modulation of activity by both ligands effectively amounts to 
signal integration. It can be used by the cell to perform certain actions only 
in cases, for example, where both ligands are present at certain 
concentrations. In this case, both ligands were chosen to bind more tightly 
to the active states of their respective domains, but repressing signals can 
also modulate receptor function.  
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Figure 4.3 A realistic model of signal transduction, inspired by VirA 
protein of the VirA/VirG two-component system. 
 (A) In addition to the domains and states in the model presented in Figure 
4.2, there is an additional cytoplasmic linker domain, with its own active 
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and inactive states, which is modulated by the signaling ligand C, different 
from ligand L which modulates the receptor. The total number of states in 
this system is 64, and for clarity only the fully inactive and the fully active 
states are diagramed. (B) Activation, relative to resting state, is plotted 
against increasing concentration of ligand L, in the presence of different 
concentrations of C. This illustrates the ability to integrate signals from 
multiple ligands. Though this model does not explicitly treat the receptor 
as being dimeric (as is the case for the VirA protein), it can be easily 
extended to do so. In this case, binding of ligand may or may not be 
coupled of receptor dimerization and there may exist cooperativity 
(negative or positive) between the two ligand-binding sites. Potential 
scenarios that can be explored include: 1) binding of a single ligand may 
push the system towards the active state, whereas binding two ligands 
symmetrically may favor the inactive state 2) alternatively, the receptor 
may signal only when two ligands are bound, or 3) binding of the second 
ligand may proceed independently of the first one. 
 
Inside-to-Outside Coupling in Integrins Receptors 
Integrins are α−β heterodimeric adhesion receptors that mediate 
interactions between the extracellular environment and the intracellular 
cytoskeleton (6, 95, 136-138) and demonstrate how bidirectional 
transmembrane signal transduction is fine-tuned by multiple coupled 
equilibria in the extracellular, transmembrane, and cytosolic domains 
(Figure 4.4A). Integrin ectodomains contain a large globular N-terminal 
ligand binding “head” and distinct C-terminal α and β “legs” that cross the 
plasma membrane as single TM domains and terminate in short 
cytoplasmic domains that bind intracellular molecules. The inactive 
integrin adopts a bent conformation placing the head in proximity to the 
membrane and the distal legs. Upon activation, an extended conformation 
is favored and the α and β legs, TM, and cytoplasmic domains separate.  
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Figure 4.4 Thermodynamic model of integrin signaling. 
 (A) At the coarsest level, extracellular, TM, and intracellular domains of 
integrins can be thought as being either active or inactive, giving rise to 
eight coupled states as illustrated. The various effector molecules 
modulate integrin state by preferentially binding to select domain 
conformations. “Inside-out” signaling refers to modulation of the 
extracellular domain conformation via interactions between an integrin’s 
cytosolic tails and intracellular signaling molecules. “Outside-in” events 
sometimes refer to the activation of oligomerization dependent signaling 
pathways subsequent to binding polyvalent ligands. However, keeping 
with our model, here it will refer to the ability of extracellular ligands to 
affect the conformation and function of intracellular domains.  (B) Using 
reasonable values for the energy gaps and coupling constants associated 
with these states as well as equilibrium binding constants for the active 
and inactive states of different effector molecules, one can interrogate the 
thermodynamics of integrin signaling in a coarse, semi-approximate 
manner. Shown here is the level of integrin activation (separation of 
TM/tail regions) in response to increasing amounts of an activating 
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antibody, as a function of Mn2+ concentration. This illustrates outside-in 
signaling. (C) AND (D) Inside-out signaling as illustrated by the fraction of 
extracellular domain bound to native ligand as a function of different 
amounts of active intracellular talin and kindlin. The binding affinity of the 
ligand as well as the amounts of talin/kindlin all couple to determining the 
activation state of the integrin.   
 
 Interactions between the α and β chain legs, TM, and membrane 
proximal cytosolic domains, stabilize the inactive integrin. Single point 
mutations result in receptor activation (15, 18, 139, 140) and membrane 
proximal abdisulfide cross-linking completely abrogates TM signal 
transduction in either direction (141, 142). While structural studies suggest 
that there is a distinct TM interface, the membrane proximal regions are 
dynamic (15, 16, 40, 142, 143), befitting the need for rapid signal 
transduction.  
The “loose” dynamic interactions between the α and β chains near 
the membrane give way to an extensive interface between globular 
portions of the extracellular domain, which can be perturbed via 
mutagenesis (144). Thermodynamic coupling occurs throughout the 
globular ectodomain. Crystallization with and without ligand resulted in 
active-extended (145) and inactive-bent (146, 147) conformations 
respectively.  Soaking the inactive crystals with a ligand resulted in only 
small-scale changes in the binding site without leg extension due to crystal 
contact constraints (148).  Without such constraint, anti-integrin drugs can 
generate adverse side effects by activating the receptor and generating 
immune reactive epitopes or Ligand Induced Binding Sites (LIBS) in the 
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integrin legs (138).  Small molecule drugs can also uncouple subdomains. 
Allosteric inhibitors that compete for inter-domain contacts generate 
functionally split integrins in which the head is locked into an inactive 
conformation, but distal regions generate active LIBS(149). LIBS 
antibodies also shift the integrin equilibrium to an active conformation. 
Constraining the integrin C-termini stabilizes the bent conformation and 
the inactive ligand binding site, but the addition of LIBS antibodies and 
Mn2+ (an second allosteric activator) shifts the head domain equilibrium to 
an active state despite the distal constraints(150). Demonstrating 
bidirectionallity, LIBS antibodies induce TM separation when not 
constrained(18).  The combination of LIBS antibody and a second 
activator, Mn2+, further increased activation, while Mn2+ alone did not 
significantly affect TM separation. Therefore, as in the case of VirA/VirG 
(Figure 4.3), multiple stimuli are integrated to produce different 
intracellular responses (modeled Figure 4.4B). 
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Figure 4.5 Coupled equilibria linking integrin TM interactions to 
cytosolic events. 
Integrin αβ TM heterodimers (left) stabilize inactive ectodomain 
conformations and TM separation (right) stabilize active ectodomain 
conformations. The αβ heterodimer stabilizes interactions between the β-
cytoplasmic domain and the inner leaflet of the bilayers (top). Cytosolic 
proteins talin-1 and kindlin-3 shift the equilibrium towards an active 
conformation by the stabilizing extended cytoplasmic domain and 
separated TM domains (bottom right).    
 
While the integrin cytoplasmic domain is much shorter (~5-6 kD for 
β-integrins) than the ectodomain, it also integrates multiple signals to 
modulate extracellular function. There is convincing evidence of a defined 
αIIbβ3 TM interface, however, the membrane proximal and cytoplasmic 
domains have not provided consistent structures (15, 16, 38, 39, 54, 151). 
In Chapter 2, we describe the NMR structure and the dynamics of the αIIb 
and β3 membrane proximal domains (1). The αIIb cytoplasmic domain 
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was disordered, but caused a kink in β3 that was predicted to stabilize the 
interaction of two β3 cytoplasmic helices with the bilayer.  Significantly, 
these dynamic membrane interacting helices contain the primary motifs 
that bind the evolutionarily related talin and kindlin families of proteins 
(reviewed in (20) and (19)).  Figure 4.5 outlines a simple linked equilibrium 
model, which is quantitatively described in Figure 4.4C/D, for how coupling 
between talin and kindlin binding motifs allows differentiation between 
ligands with different affinities for the receptor, effectively recapitulating an 
intermediate affinity state without the need for distinct extracellular 
conformations (149, 150).  This model is further elaborated upon below.   
 
  
 
IV.  Coupling between integrin and kindlin subdomains 
produces distinct integrin activation states. 
Our model of αIIbβ3 describes the integrin as series of 
thermodynamically coupled subdomains (Figure 4.6A).  Each has an 
intrinsic gapG∆ and a coupling parameter cG∆∆  that describes 
communication between subunits. The goal of this model is to 
demonstrate that the presence of multiple intracellular regulatory domains 
can result in a range of apparent extracellular affinity states that do not 
require distinct ectodomain conformations.  The studies reviewed above 
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demonstrate that there is interdomain communication in the ectodomain 
that is coupled to the TM state. Our HDX results with model integrin 
cytoplasmic domains demonstrate that despite its short sequence, there is 
also communication between the TM and both the talin binding site and 
the distal kindlin site.  This establishes a path of communication from the 
kindlin and talin sites to the ligand binding site.   
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Figure 4.6 Simplified domain structure of αIIbβ3. 
αIIbβ3 contains a series of thermodynamically coupled subdomains that 
bind allosteric regulators.  (A) The β3 chain was modeled containing six 
subunits from the N-terminal ligand binding site (1) to the distal C-terminal 
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kindlin binding site (6). Each subunit an intrinsic equilibrium (∆Ggap).  
Adjacent subunits are thermodynamically coupled (∆∆GC). (B) With the 
exception of the TM, each subdomain recognizes a specific ligand that 
modulates the equilibrium between active and inactive conformations.  In 
the case of sudomain (1), the natural ligand would be fibrinogen.  
Subdomain (2) includes the Mn2+ binding site (Mn2+ increases ligand 
fibrinogen to αIIbβ3). Subdomain (3) can bind LIBS antibodies.  The 
combined active/inactive and ligand bound/ligand free states result in four 
states per domain.  The TM does not have a ligand and therefore has only 
2 states.  Talin-1 and kindlin-3 ind regions (5) and (6) respectively.   
 
As actual thermodynamic parameters for each subdomain are 
unknown, this model is mearly illustrative and intended to demonstrate the 
functional effects of communication between integrin subunits and not to 
make specific arguments as to their actual values. Thermodynamic 
parameters were chosen to conform to published data when possible and 
to fit with our experimental results.  Without TM constraints, the integrin 
ectodomain equilibrium lies only slightly towards the inactive state (150) 
(152). Therefore a gapG∆  of only 1 kcal/mol for each extracellular 
subdomain was used.  We assumed that the coupling energy between 
subdomains was relatively high, lying between 3 kcal/mol and 6 kcal/mol.  
The gapG∆  for the TM domain was chosen to be 3 kcal/mol as this site is 
the most sensitive to mutation and removal of the TM results in partial 
activation.  Each subdomain can bind a ligand with different affinities for 
the active and inactive states.  This ratio, AI KK , which was held to 1000 
i.e. activating ligands prefer the active conformation 1000 fold more than 
the inactive. Each subdomain can populate four states:  1) active without 
ligand; 2) active with ligand; 3) inactive without ligand; and 4) inactive with 
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ligand.  The TM domain, does not have a ligand and populates only two 
states, active (separated) and inactive (heterodimeric) states.  The affinity 
for talin-1 and kindlin-3 was assumed to be 100 nM, which is of the order 
of magnitude observed in our ITC experiments in Chapter 3.  
Thermodynamic coupling between extracellular, TM, and 
cytoplasmic domains allows dynamic regulation of ligand 
binding.   
 With no allosteric modulator, fractional occupancy of αIIbβ3 is 
dependent on the intrinsic equilibrium of the receptor, gapG∆ and cG∆∆ , 
affinity for the ligand, and the ligand concentration (Figure 4.7A).  Any 
regulatory protein, such as talin-1, that binds preferentially to the active 
conformation of the cytosolic domain will shift the extracellular ligand 
binding curve to the left, increasing the apparent affinity of the receptor 
(comparing Figure 4.7A and 4.7B).  Likewise, a negative regulator can 
stabilize the inactive conformation and shift the equilibrium to the right 
(comparing Figure 4.7A and 4.7C).   
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Figure 4.7 Binding of regulatory proteins to the integrin cytoplasmic 
tail affects receptor occupancy. 
The fractional occupancy of a model integrin receptor was plotted as as a 
function of extracellular ligand concentration.  Four different ligands were 
modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM, solid ball; 10 µM, 
dashed ball). Thermodynamic parameters for integrin subdomains are 
displayed to the right.  (A) Receptor occupancy without a regulatory 
protein. (B) Receptor occupancy in the presence of a distal activator such 
as talin (KA = 100 nM, KI = 100 µM).  (C) Receptor occupancy in the 
presence of a distal inhibitor such as talin (KA = 100 nM, KI = 100 µM). 
 
 On the surface of platelets, αIIbβ3 is surrounded a high affinity 
ligand, fibrinogen, which has a serum concentration between 5 and 10 µM, 
well above its approximate Kd of 3-10 nM (153). Therefore, the intrinsic 
equilibrium of the receptor must favor the inactive state strongly to prevent 
spurious clotting and activation requires allosteric regulation via talin-1 and 
kindlin-3.  In the absence of communication between the intracellular and 
extracellular domains (
cG∆∆ = 0), receptor occupancy is independent of the 
talin-1 concentration and depends only on the overall gapG∆  of the 
ectodomain, the ligand concentration, and the ligand’s affinity for the 
integrin (Figure 4.8A).  Coupling through the TM results in ligand binding 
that is dependent on the concentration of active talin-1 (Figure 4.8B).  
There is minimal binding to even strong ligands (Kd = 10 nM) in the 
absence of talin-1, while receptor occupancy approaches 100% upon 
talin-1 activation.  This produces switch-like behavior, in which the 
receptor up-regulates affinity for a given ligand in the presence of minimal 
background activity.  Even weaker ligands, with affinities of 100 nM and 1 
µM, have occupancies approaching 80% and 30%, respectively. If the 
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coupling energy is reduced from 6 kcal/mol to 3 kcal/mol, then dynamic 
range of the receptor decreases significantly.  There would be 50% 
occupancy for a strong ligand (Kd = 10 nM) in the absence of talin and 
90% occupancy at saturating concentrations of talin-1 (Figure 4.8C).  A 
slightly weaker ligand with an affinity of 100 nM would have approximately 
10% occupancy in the absence of talin-1 and 40% at saturating talin-1 
concentrations.  The 1 µM ligand would have neglible binding even at 
saturating talin-1 concentrations.   
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Figure 4.8 Thermodynamic coupling between subdomains increases 
ligand binding dynamic range. 
The fractional occupancy of a model integrin receptor as a function of 
talin-1 concentration in the presence of 10 µM extracellular ligand.  Four 
different ligands were modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM, 
solid ball; 10 µM, dashed ball). Thermodynamic parameters for integrin 
subdomains are displayed to the right. (A) Receptor occupancy without 
coupling through the TM.  (B) Binding of ligands with affinities between 10 
nM and 10 µM to the integrin with 6 kcal/mol coupling between 
subdomains as a function of talin-1 concentration. (C) Receptor 
occupancy with 3 kcal/mol coupling between subdomains as a function of 
talin-1 concentration. 
 
Coupling between talin-1 and kindlin-3 produces distinct 
functional states.   
 The ability of cells to discriminate between different integrin ligands 
has been attributed to the existence of distinct conformations in the 
ectodomain (150, 154).  However, this effect can also be produced by 
coupling between multiple regulatory domains.  To demonstrate this, weak 
thermodynamic coupling was introduced between the talin-1 and kindlin-3 
binding sites (
cG∆∆  = 2 kcal/mol).  Binding of talin-1 (Figure 4.9A) or 
kindlin-3 (Figure 4.9B) to the integrin cytoplasmic tail results in distinct 
extracellular functional states.  Kindlin-3 produces much lower ligand 
occupancy than talin-1, since its communication to the TM and the rest of 
the receptor is dampened by the gapG∆
 
of the talin-binding site.  Already, 
this produces two distinct extracellular states.  The talin-only state has 
higher occupancy than the kindlin-only state.  For example, in the 
presence of 100 µM talin, the integrin would bind the 10 nM and 100 nM 
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ligands with 90% and 50% occupancy, respectively (Figure 4.9A, black 
line).  In contrast, the same concentration of kindlin-3 would produce only 
10% and ~1% occupancy, respectively (Figure 4.9B, black line).  
Simultaneous binding of talin-1 and kindlin-3 to the integrin would produce 
further activation states.  For each talin-1 concentration (white/grey/black 
bars) an increase in occupancy can be produced by the addition of kindlin-
3 (Figure 4.9A and 4.9C).   For example, if a cell were to activate both 
talin-1 and kindlin-3, there would be 50% occupancy of a ligand with a 1 
µM dissociation constant (Figure 4.9C, black line).  By down regulating 
kindlin-3, but maintaining the same level of talin-1, a cell could release the 
1 µM ligand, but still bind higher affinity ligands (Figure 4.9A, black line).  
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Figure 4.9 Multiple integrin regulators can produce diverse activation 
states. 
The fractional occupancy of a model integrin receptor as a function of 
talin-1 or kindlin-3 concentration in the presence of 10 µM ligand.  Four 
different ligands were modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM, 
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solid ball; 10 µM, dashed ball). Thermodynamic parameters for integrin 
subdomains are displayed to the right. (A) Receptor occupancy in the 
presence of talin-1, without kindlin-3 binding. White, grey, and black 
vertical lines mark 1 µM, 10 µM, and 100 µM of talin-1, respectively. (B) 
Receptor occupancy in the presence of kindlin-3, without talin-1. White, 
grey, and black vertical lines mark 1 µM, 10 µM, and 100 µM of kindlin-3, 
respectively. (C) Receptor occupancy as a function of talin-1 
concentration, with a constant kindlin concentration (5 µM). White, grey, 
and black vertical lines mark 1 µM, 10 µM, and 100 µM of talin-1. 
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Chapter 5. Conclusions 
 
We hypothesized that cytosolic regulation of the integrin αIIbβ3 is 
highly dependent on the membrane environment and uses coupled 
equilibria to transmit signals to the extracellular compartment.  To test this, 
we studied the dynamics and structure of model αIIbβ3 cytoplasmic 
domains in the presence of phospholipids and detergents (Chapter 2).  
We showed that interactions in the integrin TM domain are coupled to 
structural changes in the αIIbβ3 cytoplasmic domain.  The interaction 
between αIIb and β3 stabilizes a kink in the β3 cytoplasmic domain, which 
is likely to encourage interactions with the inner leaflet of the plasma 
membrane.  These interactions occur in two helical regions that include 
the talin-1 and kindlin-3 binding sites.   This demonstrates that both the 
talin-1 and kindlin-3 sites are coupled to the interactions between the αIIb 
and β3 TM domains, suggesting a pathway whereby both talin-1 and 
kindlin-3 can affect the TM state and therefore the affinity of the 
ectodomain for fibrinogen.   
We also investigated the interactions between αIIbβ3 and its two 
regulators, talin-1 (Chapter 3) and kindlin-3 (Appendix A1). Preliminary 
studies showed that kindlin-3 binds the distal segment strongly in the 
absence of membrane.  The distal kindlin-binding sequence is very 
dynamic and likely samples the cytoplasmic compartment frequently 
(Chapter 2).  This suggests that kindlin-3 may bind the β3 cytoplasmic 
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domain without requiring a concerted interaction with the membrane, 
though membrane colocalization could serve to increase its affinity.  This 
contrasts with talin-1.  We showed that talin-1 binding to the integrin 
cytoplasmic domain is dependent on concerted interactions with the 
bilayer as its affinity for β3 increases nearly 1000 fold when the integrin is 
immobilized onto negatively charged membranes.  Though the membrane 
significantly increases the affinity of talin-1 for the β3 cytoplasmic domain, 
its affinity for the integrin in the presence of membranes is not significantly 
higher than its affinity for negatively charged phospholipids alone. 
Similarly, we found that though talin-1 contains multiple lipid binding 
subdomains and that the interactions between these subunits and the 
bilayer are not cooperative. These results suggest that activation of the 
integrin by talin-1 is not opitimized for extremely high affinity as would be 
expected for perfectly cooperative interactions.  Rather the energetics of 
the system suggest that the interactions are evolved for reversibility and 
sensitivity to changes in structure, post-translational modification, and lipid 
environment.  
Fine-tuning of the integrin cytoplasmic domain for regulation and 
reversibility is befitting a receptor that must make dynamic interactions 
with the extracellular environment.  Using a simple linked equilibrium 
model, we showed that coupling between the TM and the talin-1 and 
kindlin-3 binding sites can produce a range of extracellular functional 
states. Different affinity states for extracellular ligands are due to a change 
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in the distribution of active and inactive states rather than adoption of 
specific intermediate extracellular conformations.  Integrins can access a 
large range of affinity states by simply shifting the relative amounts of 
talin-1 and kindlin-3 interacting with the cytoplasmic tail.  
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Appendix 1.  Preliminary investigations of the 
interaction between kindlin-3 and αIIbβ3  
 
I.  Introduction. 
 Among FERM domain proteins, the kindlins (kindlin-1, kindlin-2, 
kindlin-3) are evolutionarily the closest to the talin family.  Like talin-1, 
kindlin-3 binds to the β3 integrin cytoplasmic domain and is necessary for 
platelet integrin activation (7-10, 22).  As the role of kindlin-3 in integrin 
function has only recently been appreciated, its mechanism of integrin 
regulation remains largely unclear.  Talin-1 and kindlin-3 F3 subunits bind 
adjacent regions within the β3 cytoplasmic domain though it is unknown 
whether they bind simultaneously (22, 155).  Talin-1 recognizes a 
segment that spans from the end of the TM to Tyr747 and includes 
TMproxH and CytoH1.  Kindlin-3 recognizes a distal segment that 
immediately follows the talin-1 binding sequence, spanning from Ser752-
Tyr759, and including CytoH2 (Figure 2.5).  Both proteins require intact 
NPxY or NxxY motifs to bind (22, 155).  The spacing between the talin-1 
and kindlin-3 NPxY motifs is absolutely conserved in nearly all integrins, 
with the exception of the β5 integrins.    
Like talin-1, the kindlin-3 FERM domain contains an additional F0 
subunit.  Whether kindlin-3 adopts a linear arrangement of like talin-1 
(Figure 3.1) is unknown, since the structure of kindlin-3 has not been 
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solved.  The kindlin-3 FERM domain also contains an inserted pleckstrin 
homology (PH) domain in its F2 subunit, which talin-1 lacks.  The function 
of the PH domain has yet to be demonstrated, though PH domains – and 
FERM domains in general – are often involved in phospholipid interactions 
(26).  
Our HDX data suggest that the β3 cytoplasmic domain makes 
significant interactions with the bilayer.  In particular, the portion that binds 
talin-1 is significantly protected from HDX in the presence of 
phospholipids.  Furthermore, our NMR experiments show that αIIb 
induces a kink in the β3 cytoplasmic domain, which is likely to orient the 
β3 CT parallel to the membrane and further stabilize the interaction. We 
also have shown that the interaction between talin-1 and β3 is quite weak 
and requires a simultaneous interaction between talin-1 and the 
membrane to be significantly populated.  In contrast, our HDX and NMR 
experiments have shown that the kindlin-3 binding sequence in β3, which 
is connected to the talin-1 sequence by a flexible linker, is highly dynamic 
and less helical and therefore less likely to bind the competing membrane 
surface.  Based upon these results we hypothesized that the kindlin-3 
sequence is more accessible than the talin-1 sequence, whether or not the 
protein/peptide interaction is more thermodynamically stable.  A more 
dynamic kindlin-3 binding sequence would also not adopt a particular 
orientation relative the inner surface of the bilayer.  This would suggest 
that unlike talin-1, kindlin-3 binding to the integin might be less dependent 
125 
 
on simultaneous interactions with the membrane. If this were the case, 
then kindlin-3 might bind the β3 CT with reasonably high affinity in the 
absence of membranes.  Below are initial experiments attempting to 
characterize the interaction between kindlin-3 and β3 to test the above 
model.  We describe method for the purification full-length kindlin-3 from 
platelets and demonstrate that kindlin-3 binds to the β3 CT in the absence 
of bilayers.  These are initial experiments that are intended to be the 
starting points for future lab members.   
 
II.  Results 
Purification of kindlin-3 from human platelets.   
 Kindlin-3 constructs were cloned into the pet28a vector and 
expressed in BL21-DE3 E. coli.  However, expression of constructs 
containing full-length kindlin-3, the F2PHF3 subunit, and the F3 subunit 
resulted in insoluble inclusion bodies.  We varied our expression 
conditions with temperatures ranging from 8°C to 37°C and IPTG 
concentrations ranging from 0.05 mM to 2 mM.   However, only the 
isolated PH domain could be stably expressed in E. coli.  We therefore 
purified full-length kindlin-3 from outdated platelets.   Given its close 
homology to talin-1 and its localization to membranes, it was likely that 
kindlin-3 also contain positively charged surfaces. Therefore, the 
purification scheme (Methods) was designed around separation based on 
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charge. After several rounds of SP-Sepharose and size exclusion 
chromatography, we produced nearly 10 mg of 95% pure kindlin-3 from 
six units of outdated platelets (Figure A1.1A/B).  The predicted molecular 
weight for kindlin-3 is 75.4 kD and the purified protein had a calculated 
molecular weight of 74 kD by equilibrium analytical ultracentrifugation 
(Figure A1.1C).   
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Figure A1.1 Purification of Kindlin-3 from platelets. 
 (A) Kindlin-3 was purified by several rounds of cation exchange 
chromatography (Methods) and refined by size exclusion on an analytical 
Superdex-200 column.  (B) Analytical size exclusion chromatography 
fractions were run on NuPAGE SDS 10% Bis-Tris gels and stained with 
Coomassie Blue stain. Higher order aggregates eluted in the void volume 
(Fraction 1).  Kindlin-3 eluted between 13 and 15 minutes (Fractions 2-8) 
and was found between the 66 kD and 97 kD bands of a Mark12 
molecular weight standard.  (C) Equilibrium analytical ultracentrifugation of 
the purified protein.  Kindlin-3 was prepared in 25 mM MOPS 100 mM 
NaCl, pH 7 at 3 µM (left) and 1.5 µM (right).  The samples were 
sedimented at 15000 rpm, red/green, 20000 rpm, dark blue/black, and 
25000 rpm, light blue/brown.  Data were globally fit using the Igor software 
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program to a MW of 74 kD.  {AUC experiments were performed once.  
Performed by DTM with the guidance of PB.} 
 
Preliminary experiments suggest kindlin-3 binds β3 with high 
affinity in the absence of bilayers.   
Our HDX and NMR measurements of the β3 cytoplasmic domain 
showed that the kindlin-3 binding sequence is very dynamic and likely 
adopts many conformations relative to the membrane surface.  We 
therefore hypothesized that, unlike talin-1 interaction with β3, kindlin-3 
might not depend on a coordinated interaction with the bilayer surface.  If 
this were the case, then the complex between kindlin-3 and β3 should be 
stable at much lower concentrations than the interaction between talin-1 
and β3. We used analytical ultracentrifugation to measure the interactions 
of labeled β3 with both talin-1 and kindlin-3 in the absence of membranes.  
In each case 1 µM of BODIPY TMR labeled β3 CT (MW 6242 kD, 
prepared as in Chapter 2 for FP) was sedimented in the presence of 
excess kindlin-3 (3.5 µM or 1.75 µM) or excess talin-1 (10  µM).  In the 
presence of 10 µM talin-1, labeled β3 cytoplasmic domain sedimented 
with an apparent molecular weight of 7.7 kD (Figure A1.2A), which is close 
to its predicted monomeric 6.2 kD mass.  In the presence of kindlin-3, 
there was a clear shift towards higher molecular weight species. Global 
fitting of both kindlin-3 concentrations resulted in estimation of a 
dissociation constant between 100 nM and 3 µM (Figure A1.2B).  Single 
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species fits produced molecular weights of 43 kD and 12 kD for the 3.5:1 
and 1.75:1 experiments, respectively, suggesting a Kd on the order of 
several micromolar.   However, without higher concentrations of kindlin-3 
and β3, it is impossible to calculate the affinity for β3 with higher accuracy.  
This would require more kindlin-3 than could be prepared for the 
experiment. 
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Figure A1.2 Equilibrium AUC of Kindlin-3 and β3.   
(A) Equilibrium AUC of 10 µM talin-1 and 1 µM BODIPY TMR-β3.   
Sedimentation was monitored at 600 nm.  The sample was sedimented at 
four velocities (10000 rpm black, 15000 rpm blue, 20000 rpm green, 
25000 rpm red).  Data were globally fit to a single species of 7.7 kD using 
Igor.  (B)Kindlin-3 and BODIPY-β3 were combined in two ratios: 3.5 µM 
kindlin-3 and 1 µM BODIPY-β3 (left) and 1.75 µM kindlin-3 and 1 µM 
BODIPY-β3 (right).   Sedimentation AUC was performed while monitoring 
600 nm absorbance at three velocities (15000 rpm red/brown, 20000 rpm 
dark blue/light blue, and 25000 rpm green/black).  Sedimentation was 
globally fit to a two species 1:1 binding model with the ε600 for Kindlin 
held to 700 cm-1M-1 and ε600 for BODIPY-β3 held to 70000 cm-1M-1.  Due 
to the low protein concentration and absorbance relative to background, 
sedimentation fit equally well to dissociation constants between 100 nM 
and 3 µM.  {AUC performed once by DTM under the guidance of PB.} 
 
III.  Methods 
 
Kindlin-3 purification. Six to 10 units of outdated platelets (Hospital of the 
University of Pennsylvania Blood Bank) were lysed by N2 bomb on ice in 
the presence of mammalian protease inhibitors and 10 mM EDTA, 100 
mM NaCl.  EDTA was necessary to prevent significant proteolysis of 
kindlin-3.  Lysates were centrifuged at either 30k x g or 100k x g to clear 
insoluble debris.  After clearance, lysates were mixed with Q-Sepharose 
batch-wise for 1 hour at 4 degrees Celsius to clear serum and negatively 
charged proteins.  The cleared lysate was loaded onto SP-sepharose (25 
mL) in 50 mM NaCl batchwise and poured into a high-pressure FPLC 
column for elution on gradient between 50 mM NaCl and 400 mM 
Arginine, pH 7 on a Akta FPLC (GE Healthcare).  The kindlin-3 containing 
fractions were then concentrated and loaded onto a high resolution SP-
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sepharose column (16/10, 25 mL bed volume) (GE Healthcare) and eluted 
over a 400 mL gradient.  At this point, the primary impurities were full 
length talin and talin head domain, which were largely removed by size 
exclusion on Superdex200 or Superdex75 analytical column (200 uL 
injection volume) (GE Healthcare).  A final high resolution SP sepharose 
step was performed on a 400 mL gradient to 400 mM Arginine.   
 
Equilibrium Analytical Ultracentrifugation.  Purified peptide and protein 
samples were prepared in 25 mM MOPS 100 mM NaCl, pH 7.0.  
Experiments were performed at 25°C.  Samples were loaded into a 6-
channel carbon-epoxy centerpiece and centrifuged at 10000 rpm, 15000 
rpm, 20000 rpm, and 25000 rpm in a Beckman XL-I analytical 
ultracentrifuge.  Samples were monitored at 280 nm and 600 nm in a 1.2 
cm path length cell.  The molecular weight and partial specific volumes of 
kindlin-3 were calculated to be 75.4 kD and 0.73 ml/g, respectively using 
SEDINTERP.  The buffer density was calculated to be 1.003 g/ml.  Data 
were globally fit using Igor Pro (Wavemetrics).   
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Appendix 2.  NMR studies of the c-Src SH3 domain 
and the β3 cytoplasmic domain.    
 
I.  Introduction 
Src family kinases (SFKs) are a family of non-receptor tyrosine 
kinases implicated in a number of biological processes (156, 157).  There 
are nine human SFKs expressed—often redundantly—in nearly all human 
tissues (158). Of the SFKs, c-Src is the best studied, being discovered as 
the first proto-oncogene in the 1970s (159).  Redundancy in SFK paralog 
expression has resulted in single-gene knockout phenotypes that are 
unremarkable, especially in the case of platelets (158).  In order to 
observe a significant platelet phenotype, it was necessary to generate 
platelets deficient in six kinases (c-Src, Fyn, Fgr, Hck, Lyn, and Yes), 
which resulted in reduced platelet spreading on the αIIbβ3 ligand 
fibrinogen (160).  These gene-deleted platelets and wild-type platelets 
treated with SFK inhibitors do not have a defect in integrin activation or 
ligand binding.  Rather they have a downstream defect in tyrosine 
phosphorylation and cytoskeletal mobilization after initial adhesion to 
fibrinogen, suggesting that SFKs participate in platelet integrin outside-in 
signaling, which is supported by the fact that SFKs are recruited to the 
integrin associated cytoskeleton after platelet aggregation (161, 162) and 
that c-Src activation requires binding of αIIbβ3 to fibrinogen (160).   
SFKs contain well-conserved domain structures (Figure A2.1).  
Each SFK contains an N-terminal membrane anchor followed by a flexible 
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linker (black), a Src Homology 3 (SH3, purple) domain, a flexible linker 
(blue), a Src Homology 2 (SH2, green) domain, a flexible linker (yellow), 
the kinase domain (orange), and then finally a C-terminal regulatory tail 
(red).  Inactive SFKs adopt compact structures that are stabilized by 
multiple intramolecular interactions  (163).  In the inactive state, the 
phosphotyrosine recognizing SH2 domain (green) binds to the 
phosphorylated C-terminal tail (red).  The inactive conformation is also 
stabilized by an interaction between the SH3 (purple) domain and a 
second internal ligand in the linker (yellow) between the SH2 and kinase 
domains. C-terminal Src Kinase (CSK) phosphorylates the C-terminal tail 
(164), while protein-tyrosine phosphatase-1B (PTP-1B) activates the 
kinase by dephosphorylating the C-terminus (165).  Activation also 
requires phosphorylation of a regulatory loop in the kinase domain.  
In the active state, the SH2 and SH3 domains are free to interact 
with other proteins.  Such interactions stabilize the active kinase state and 
determine the localization of SFKs (156).  Localization also depends on 
the N-terminal membrane anchor.  All SFKs are myristoylated and a 
subset are palmitoylated (166, 167).  C-Src is not palmitoylated and 
contains a conserved patch of positively charged Arg and Lys residues 
(Figure A2.1), which has been demonstrated necessary for binding of c-
Src bilayers containing negatively charged phospholipids such as 
phosphatidylserine and phosphatidylglycerol (25) (29).  
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Figure A2.1  Domain structure of c-Src in its inactive conformation.   
From N- to C-terminus:  1) N-terminal membrane anchor that is post-
translationally myrstoylated (Black).  C-Src contains a stretch of basic 
amino acids (bottom).  2) SH3 domain (purple)  3) Interdomain linker 
(blue).  4) SH2 domain (green).  5) SH2-kinase linker (yellow) 6) Kinase 
domain (orange).  7) C-terminal regulatory tail (red).   
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 SFK substrate specificity appears to be less dependent on the 
substrate sequence than physical proximity (168). Therefore, the 
specificity of SFK protein-protein and protein-lipid interactions is extremely 
important in determining function. Recruitment to integrin signaling 
complexes could potentially involve the N-terminal membrane anchor, the 
SH3 domain, and the SH2 domain.  Both the SH3 and SH2 subunits of c-
Src have been shown to interact with Focal Adhesion Kinase (FAK) (169) 
and p130Cas(170, 171), two proteins found in integrin signaling 
complexes.  A number of studies have also suggested that c-Src binds 
directly to the last three residues (Arg760-Gly761-Thr762) of the β3 
integrin cytoplasmic domain (23). Transgenic platelets containing 
mutations in this region exhibited defects in spreading and down-stream 
integrin events (137, 172).  The Arg-Gly-Thr motif implicated in the c-Src / 
β3 interaction is quite different from the canonical polyproline sequence 
recognized by the c-Src SH3 domain (Figure A2.2B) (173).  The 
polyproline backbone packs against a groove composed of aromatic 
residues (Tyr93, Tyr95, Tyr139) (174, 175).   A specificity pocket defined 
by Trp121 and Tyr134 is at the end of the aromatic groove and is flanked 
by the n-Src loop and the RT-loop, which affect substrate specificity (173).   
We hypothesized that the β3 cytoplasmic domain may bind to the c-
Src SH3 domain either along the Tyr-groove or in the aromatic specificity 
pocket.  We characterized integrin/SH3 interaction using biophysical 
techniques sensitive to perturbation at these residues.  We were surprised 
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to find that the interaction is much weaker than predicted by published 
biological and biochemical studies(23, 137, 172), suggesting that the 
interaction may depend on other proteins or the lipid environment. 
 
Figure A2.2. The interaction between the c-Src SH3 domain and a 
polyproline peptide. 
Interaction between the c-Src SH3 domain and a polyproline peptide 
(yellow) is shown down the axis of the peptide (A) and rotated 90° (B).  
The interaction requires packing of the polyproline backbone against an 
aromatic groove and “specificity pocket” composed tyrosine and 
tryptophan residues (purple).  Residues from the RT-loop and the n-Src 
loop interact with the backbone and side chains of the peptide and help 
determine the sequence specificity of the interaction  (PDB code 1nlp) 
 
II.  Results 
C-Src, β3 integrin, and polyproline constructs.   
  The c-Src SH3 domain was cloned between residues Ala83 and 
Ser143 into the pet28a vector with an N-terminal 6xHis tag followed by a 
thrombin cleavage site for removal of the affinity tag. The β3 cytoplasmic 
domain (β3-NITYRGT) between residues Asn756 and Thr762 was 
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synthesized on Wang resin generating a short seven amino acid peptide 
containing the Arg-Gly-Thr binding motif c-Src binding motif.  Wang resin 
was chosen because the resulting peptide contained a C-terminal 
carboxylate like the natural sequence.  The polyproline peptide Arg-Pro-
Leu-Pro-Pro-Leu-Pro with a C-terminal amide was synthesized on Rink-
amide resin.   
Circular dichroism and Trp-fluorescence of c-Src SH3 domain 
and the β3 C-terminus. 
It has been reported that c-Src co-immunoprecipitates αIIbβ3, that 
the SH3 domain interacts with the β3 C-terminus by ELISA with a 
micromolar binding binding constant, and that mutations to the β3 C-
terminal Arg-Gly-Thr sequence results in outside-in integrin signaling 
defects (23, 137, 172). Though the integrin sequence is quite different 
from the canonical polyproline ligand, we hypothesized that the interaction 
might also occur along the Tyr-groove or the Trp-containing specificity 
pocket. Changes in the local environment surrounding aromatic residues 
can often be measured by changes in CD signal or Trp fluorescence 
(176).  Binding of polyproline ligands to this region was previously 
observed using these techniques (177) (178).  We therefore attempted 
similar experiments with our β3-NITYRGT peptide, reasoning that such 
studies would support binding to the aromatic region of the SH3 domain. 
Solutions containing 40 µM SH3 domain and 650 µM β3-NITYRGT 
were prepared in pH 7.0 25 mM phosphate 100 mM NaCl.  CD spectra 
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were taken of each sample (Figure A2.3).  The SH3 domain was then 
mixed 1-to-1 with the β3-NITYRGT peptide and the CD spectrum of the 
mixture was taken (Figure A2.3A, green).  The expected spectrum for the 
mixture in the absence of interaction was also calculated by averaging the 
SH3 and β3-NITYRGT spectra (Figure A2.3A, green dash).  The 
difference between the expected and experimental CD spectra was then 
calculated (Figure A2.3A, red). There was no significant difference 
between the two, demonstrating that mixing the β3-NITYRGT peptide and 
SH3 domain resulted in no change in CD signal at the concentrations 
used.  However, when similar experiments were performed with 650 µM 
polyproline RPLPPLP (Figure A2.3B), a clear shift in the CD was observed 
(Figure A2.3B, red). The difference spectrum for RPLPPLP has a 
maximum at 225 nm, which replicates previously published results (177).  
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Figure A2.3 Comparison of CD and Trp fluorescence changes in the 
presence of a polyproline peptide and  β3-NITYRGT. 
Protein and peptide samples were prepared in 25mM phosphate 100 mM 
NaCl, pH 7.0.  (A) CD spectra were taken of 40 µM c-Src SH3 domain 
(dark blue), 650 µM β3-NITYRGT peptide (light blue), and a 1:1 mixture of 
the two samples with 20 µM SH3 and 325 µM β3-NITYRGT (green).  The 
expected spectrum in the absence of interaction was calculated by 
averaging the SH3 and β3 spectra (dashed green).   The difference 
between the actual and expected spectra was calculated (red).  (B) CD 
spectra were taken of 40 µM c-Src SH3 domain (dark blue), 650 µM 
polyproline (light blue), and a 1:1 mixture of the two samples with 20 µM 
SH3 and 325 µM polyproline (green).  The expected spectrum in the 
absence of interaction was calculated by averaging the SH3 and 
polyproline spectra (dashed green).   The difference between the actual 
and expected spectra was calculated (red). (C) Tryptophan emission 
spectra of the c-Src SH3 domain.  SH3 solutions with or without peptide 
were excited at 295 nm and emission spectra were recorded from 300-400 
nm.  Spectra were recorded for 50 µM SH3 domain alone (light blue), 50 
µM SH3 domain with 200 µM polyproline (dark blue), 50 µM SH3 domain 
with 200 µM β3-NITYRGT (green), and 50 µM SH3 domain with 200 µM 
polyproline and 200 µM β3-NITYRGT (magenta).  {CD and fluorescence 
experiments are representative of three independent experiments.  Protein 
and peptide samples were made by DTM.  Experiments were performed 
by DTM.} 
 
Binding of a polyproline ligand to the c-Src SH3 domain results in a 
blue shift in tryptophan fluorescence (178).  We reasoned that though 
mixing of the c-Src SH3 domain and β3-NITYRGT did not result in a 
significant change in circular dichroism, if the β3 peptide bound to the 
tryptophan containing specificity pocket in the SH3 domain, it might induce 
in a similar blue shift in fluorescence.  A 50 µM solution of SH3 was 
excited at 295 nm and an emission spectrum was recorded between 300 
and 400 nm, with an emission maximum at 355 nm (Figure A2.3C, light 
blue).  The same measurement was performed on a second solution 
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containing 50 µM SH3 and 200 µM β3-NITYRGT, with an emission 
maximum at 356 nm (Figure A2.3C, green). In comparison, the addition of 
200 µM RPLPPLP shifted the SH3 emission maximum to 347 nm (Figure 
A2.3C, dark blue).  Finally, the emission maximum for a sample containing 
50 µM SH3, 200 µM β3-NITYRGT, and 200 µM RPLPPLP was at 346 nm.  
These results show that unlike the polyproline peptide, the integrin 
cytoplasmic domain peptide does not cause a blue shift in the SH3 
domain Trp-emission spectrum.  Likewise, it does not compete for binding 
of the SH3 domain to the polyproline sequence.   
 
NMR titration of the β3 cytoplasmic domain the c-Src SH3 
domain. 
Our CD and Trp fluorescence experiments did not demonstrate an 
interaction between the c-Src SH3 domain and β3-NITYRGT at 
concentrations as high as 350 µM β3-NITYRGT.  We reasoned that the 
interaction was either extremely weak and not observed at the 
concentrations used or it might occur outside of the aromatic groove or 
specifity pocket and therefore CD and Trp fluorescence would not be well 
suited for the measurement. We chose to use NMR, which has 
successfully been used to study weak protein-protein interactions (179).  
The c-Src SH3 domain was expressed in 15N M9 minimal media and 
purified by nickel chromatography.  The 6xHis tag was removed using 
thrombin protease and the purified protein was transferred into pH 6.0 
142 
 
phosphate buffer containing 100 mM NaCl and concetrated.  Two NMR 
samples were prepared for 1H-15N HSQC NMR.  The first contained 1 mM 
15N SH3 (Figure A2.4, red) and the second contained 1 mM 15N-SH3 and 
15.7 mM β3-NITYRGT peptide (Figure A2.4, magenta). In the presence of 
15.7 mM β3-NITYRGT, a number of SH3 residues exhibited changes in 
chemical shift. The interaction appears to be in fast exchange, as only 
shifts in peak location were observed.  Slow exchange binding would be 
expected to generate two sets of peaks corresponding to the bound and 
unbound forms, while intermediate exchange would produce broadened 
signals of both species with potentially a loss of intensity.  In this titration, 
peaks remained sharp and intense.   
 
Figure A2.4 Changes in SH3 chemical shift in the presence of β3-
NITYRGT 
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 (A) 1H-15N HSQC spectra of samples containing 1 mM c-Src SH3 domain 
(red) and 1 mM 15N-labeled c-Src SH3 domain with 15.7 mM β3-NITYRGT 
(magenta).   Both samples were prepared in pH 6.0 20 mM phosphate 
containing 100 mM NaCl. {Samples prepared by DTM.  Experiment 
performed by DTM with help of HC.}   
The difference in the HSQC spectrum for each residue was 
calculated by the relationship ∆ppm = (∆1H2 +(∆15N/5)2)1/2 (Figure A2.5A).  
The standard deviation for the per residue chemical shift change was 
0.04.  Sixteen residues had chemical shifts greater than one standard 
deviation: Tyr95, Glu96, Arg98, Thr99, Glu100, Thr101, Asp102, Leu103, 
Phe105, Asn115, Asn116, Glu118, Trp121, Ser126, Gly130, and Tyr134.  
SH3 residues were color coded according to their chemical shift change 
and mapped onto a previously reported structure of the c-Src SH3 domain 
(Figure A2.5B/C). The majority of residues perturbed by β3-NITYRGT 
were in the n-Src and RT-loops and centered around the specificity pocket 
(Trp121 and Tyr134). The largest chemical shift changes occurred in 
residues in or adjacent to the RT-loop, especially residues Arg98 (0.25 
ppm), Glu100 (0.15 ppm), and Asp102 (0.13 ppm). Tyr93, Tyr95, and 
Tyr139 form the aromatic polyproline binding groove (Figure A2.2, 
magenta) that binds polyproline ligands.  Of these, only Tyr95, which is 
adjacent to the specificity pocket, was perturbed by β3-NITYRGT.  Tyr93 
and Tyr139 were unchanged (Figure A2.5B/C, magenta). 
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Figure A2.5  β3-NITYRGT causes chemical shift changes centered 
around the SH3 specificity pocket. 
 (A) The change in chemical shift in the presence of 15.7 mM β3-
NITYRGT (Figure A2.4) was calculated by the equation ∆ppm = (∆1H2 
+(∆15N/5)2)1/2.  (B) Chemical shift changes were color coded and mapped 
onto a previously solved NMR structure of the c-Src SH3 domain (pdb 
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code 1nlp).  The maximum chemical shift change was 0.25 ppm (red, 
Arg98).  The minimum cutoff was 0.05 (dark blue, Tyr95).  Tyr95 is part of 
the aromatic groove that binds polyproline ligands.  The remaining 
residues in the aromatic groove (Tyr93 and Tyr139) did not have 
significant changes in chemical shift and are colored magenta.   
 
The SH3 NMR sample containing 15.7 mM β3-NITYRGT was 
serially titrated against the sample containing only SH3 domain.  This 
produced NMR samples with constant 1 mM SH3 concentrations and β3-
NITYRGT concentrations ranging between 5.3 mM and 15.7 mM.  HSQC 
spectra were recorded for each sample.  Figure A2.6A shows the change 
in Arg98 chemical shift with the addition of β3-NITYRGT.  The relationship 
was linear (Figure A2.6B), indicating that the titration had not reached 
saturation and that the majority of SH3 domain was unbound, even in the 
presence of 15.7 mM β3-NITYRGT.  Since the majority of the protein was 
not bound, [SH3]total approximates [SH3]free and [β3]total approximates 
[β3]free.  Therefore, the relationship ∆(chem. shift) = ∆ppmmax * 
([SH3]free*[β3]free)/(KD*[SH3]total) simplifies to ∆(chem. shift) =[Ligand]* 
(∆ppmmax/Kd).  The term ∆ppmmax represents the change in chemical shift 
when the SH3 domain is fully bound by ligand.  As the slope is linear, it 
can be assumed that the maximum chemical shift change is on the order 
of 10 fold the observed change, or 2.5 ppm.  Since the maximum 
reasonable change in chemical shift is 5 ppm for any protein-protein 
interaction, this places the Kd between 175 mM and 350 mM..   
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Figure A2.6  1N-15N HSQC titration of β3-cytoplasmic domain and c-
Src SH3. 
 (A) 1H-15N HSQC spectrum c-Src SH3 residue Arg98 backbone amide 
without (red) and with 5.3 mM (yellow), 8.4 mM (orange), and 15.7 mM 
(purple) β3-NITYRGT. (B) Relationship between Arg98 chemical shift 
change and total concentration of β3-NITYRGT.  The change in chemical 
shift was calculated according to the equation ∆ppm = (∆1H2 +(∆15N/5)2)1/2.  
The data was fit to a linear curve with a slope 0.0153 ppm/(mM titrant).  
{Samples prepared by DTM.  Experiments performed by DTM.} 
 
III.  Discussion. 
 
Though SFKs are necessary for integrin outside-in signaling, how 
they are recruited to these signaling complexes and the degree of 
specificity built into the nine different kinases remains unclear.  SFKs 
contain multiple subunits capable of making protein-protein and protein-
lipid interactions, therefore targeting to a particular signaling complex 
could potentially require the coincidence of multiple relatively weak 
interactions.  There is clearly a degree of redundancy built into SFK 
signaling in platelets as six kinases are required to be knocked out to 
generate platelets that are unable to spread on fibrinogen.  As a starting 
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point for understanding the regulation of these processes, we have 
investigated the interactions between c-Src and the β3 integrin 
cytoplasmic domain. 
We sought to characterize the interaction between the c-Src SH3 
domain and the β3 integrin cytoplasmic domain C-terminus.  Several lines 
of evidence have suggested that the c-Src SH3 domain specifically binds 
to the β3 integrin cytoplasmic domain.  It has been shown that mutations 
to the terminal Arg-Gly-Thr sequence result in decreased spreading of 
both transfected cells (23, 180, 181) and platelets on a surface coated 
with the αIIbβ3 ligand fibrinogen(137); that mutations to this sequence 
disrupt co-immunoprecipitation of c-Src and αIIbβ3(160); that mutations to 
this sequence block solid-phase binding of GST-SH3 domain to the β3 
cytoplasmic domain (23, 181); and that a synthetic membrane permeable 
peptide containing the Arg-Gly-Thr sequence disrupts platelet c-Src 
signaling (182).  The interaction was studied in solution using monomeric 
c-Src and β3 constructs in contrast to the previously reported solid-phase 
experiments, which used a dimeric GST-SH3 fusion protein(23).  There 
was no evidence of the interaction by circular dichroism or tryptophan 
fluorescence and β3 did not compete with binding by a polyproline ligand.  
It is possible that an interaction between β3 and the SH3 occurs away 
from the canonical polyproline binding pocket, therefore we chose to study 
the interaction by NMR.  We found that addition of the β3 C-terminus does 
in fact cause chemical shift changes in the SH3 domain in the region of 
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the specificity pocket.  However this requires extremely high 
concentrations of β3 and even 15.7 mM β3 does not saturate the SH3 
domain and the calculated dissociation constant may be as high as 
several hundred millimolar.   
Typical polyproline ligands contain Lys or Arg residues that pack 
against the Trp and Tyr in the specificity pocket and make electrostatic 
interactions negatively charged residues provided by the n-Src or RT-loop.  
The β3 sequence provides a conserved Arg residue at position 759 in the 
Arg-Gly-Thr sequence and replacement of this sequence with a Glu-Gly-
Lys is reported to disrupt c-Src signaling and interactions with β3 (181).  
Further NMR studies are necessary with similar mutant peptides to 
determine whether such a sequence substitution will also disrupt the 
interaction seen by NMR.   
Our measured interaction is much weaker than that reported for 
binding of solid-supported β3.  It is possible that the differences in the β3 
cytoplasmic domain constructs used can account for the significant 
variation between our results and those reported previously.  We chose to 
use the C-terminal seven residues for our NMR experiments as these 
residues have previously been shown necessary for binding. The 
discrepancy in apparent β3 binding affinity may partially be due to avidity 
effects of surface binding by dimeric GST-SH3 fusion proteins (23, 181).  
It is also possible a third species (or more) may be necessary for the 
apparent interaction to occur under biological conditions.  The adjacent 
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sequence in the β3 cytoplasmic domain also recognizes members of the 
kindlin and filamin families of protein and therefore could conceivably 
cooperate in binding.  C-Src also binds other integrin signaling molecules 
including FAK (169) and p130Cas(170, 171).  Further studies are needed 
to characterize the recruitment of SFKs to integrin adhesions and to 
determine whether the membrane environment plays a role.   
 
IV.  Methods 
 
Protein and peptide constructs used. The c-Src SH3 domain was cloned 
between Ala83 and Ser143 into a pet28a vector between the NdeI and 
XhoI restriction sites.  Expression was performed in BL21-DE3 cells 
(Novagen).  They were grown in LB-media to an OD600 of 0.5 at 37°C 
and 1 mM IPTG was added.  After 3 hours of expression, cells were lysed 
by tip sonication on ice for 20 minutes in pH 7, 500mM NaCl, 20mM 
imidazole with a protease inhibitor cocktail (Sigma-Aldrich) containing 1 
mM EDTA.  The lysates were cleared by centrifugation at 30,000 g for 30 
minutes.  The supernatant was loaded onto a HiTrap Ni-NTA column (GE 
Healthcare) and eluted over a 50 mL gradient to 500 mM imidazole.  
Imidazole was dialyzed away overnight into pH 7.5 Tris, 100 mM NaCl, in 
the presence of thrombin protease (GE Healthcare) to remove the 6xHis 
tag.  The SH3 domain then purified away from the 6xHis tag by DEAE ion 
exchange chromatography.   
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 β3-NITYRGT was synthesized on Wang resin preloaded with a Thr 
residue using a Symphony peptide synthesizer at 0.1 mM scale in 25% 
DMSO/75% NMP with Fmoc-chemistry. β3-NITYRGT was N-terminally 
acetylated and cleaved from the resin TFA/triethylsilane/water (95/2.5/2.5 
v/v) for three hours and precipitated into dry-ice cold diethylether. β3-
NITYRGT was purified by reverse phase HPLC (Varian Prostar) using a 
C4 preparative column (Vydac) on a water/acetonitrile gradient with 0.1% 
TFA.   
 RPLPPLP was synthesized on Rink-amide resin using a Symphony 
peptide synthesizer at 0.1 mM scale in 25% DMSO/75% NMP with Fmoc-
chemistry. RPLPPLP was N-terminally acetylated and cleaved from the 
resin TFA/triethylsilane/water (95/2.5/2.5 v/v) for three hours and 
precipitated into dry-ice cold diethylether. β3-NITYRGT was purified by 
reverse phase HPLC (Varian Prostar) using a C4 preparative column 
(Vydac) on a water/acetonitrile gradient with 0.1% TFA.   
 
Circular dichroism.  Purified c-Src SH3 domain was transferred to CD 
buffer (mM phosphate 100 mM NaCl, pH 7.0) by dialysis and a stock 
containing 40 µM protein was made (calculated by absorption at 280 nm).  
Stocks of β3-NITYRGT and RPLPPLP were made in the CD buffer by 
weighing out the respective peptides dissolving them in the appropriate 
volume of buffer. CD spectra were taken on a JASCO J-810 
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spectropolarimeter. Measurements were made stepwise for each 1 nm 
between 215 nm to 240 nm and averaged over three scans at 25°C. 
 
Tryptophan fluorescence.   Stocks of purified c-Src SH3, β3-NITYRGT, 
and RPLPPLP were prepared in CD buffer.  Three samples were 
prepared: 50 µM SH3, 50 µM SH3 + 200 µM RPLPPLP, and 50 µM SH3 + 
200 µM β3-NITYRGT. All fluorescence measurements were performed at 
25°C in an Aviv Associates fluorometer.  Samples were excited at 295 nm 
using a 2 nm band-pass filter and the emission spectrum was measured 
between 300 and 400 nm with 1 nm stepping and a 2 nm band-pass filter.  
 
15N-1H HSQC NMR.  SH3 grown in M9 minimal media supplemented 
with 15N NH4Cl was transferred into pH 6.0 phosphate, 100 mM NaCl and 
concentrated to 1 mM.  NMR data were collected on a Bruker DMX-600 
spectrometer equipped with a 5-mm x,y,z-shielded pulse-field gradient 
triple-resonance probe (Bruker).  Experiments were performed at 20 
degrees Celsius.  Assignments were based upon published c-Src SH3 
chemical shifts (175).  1H-15N HSQC were acquired and analyzed in the 
Sparky software suite.  Changes in chemical shift were calculated 
according to the relationship dCS = sqrt(dH2+(dN/5)2).    
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